Compositions for use in a substance delivery system
A composition with diterpenoids and other compounds from Nicotiana species addresses the flavor and aroma gap in non-combustible smoking alternatives, enhancing the 'FMC-like' experience and increasing consumer acceptance.
Patent Information
- Application Number
- PCT/GB2026/050799
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-11
- Publication Date
- 2026-11-12
AI Technical Summary
Existing non-combustible smoking alternatives fail to fully replicate the flavor and aroma experience of traditional factory-made cigarettes, particularly in terms of richness and complexity, leading to consumer reluctance in adopting these devices.
A composition comprising diterpenoids and other compounds derivable from Nicotiana species, optionally including nicotine, is formulated to enhance the tobacco aroma and flavor profile in non-combustible substance delivery systems, replicating the 'FMC-like' experience by simulating the aroma and flavor of burning or smoking a cigarette.
The composition effectively enhances the flavor and aroma experience in non-combustible devices, providing a more authentic cigarette-like experience, thereby increasing consumer acceptance and satisfaction.
Smart Images

Figure IMGF000009_0001 
Figure IMGF000009_0002 
Figure IMGF000051_0001
Abstract
Description
COMPOSITIONS FOR USE IN A SUBSTANCE DELIVERY SYSTEMTechnical Field
[0001] The present disclosure relates to a composition for use in a substance delivery system to provide a tobacco aroma and a method of forming the composition. The tobacco aroma provided by the composition is advantageous in contributing to a factory-made cigarette (FMC)-like experience when the composition is employed in a non-combustible substance delivery system, such as a non-combustible aerosol provision device. Also provided is a consumable for use in a non-combustible substance delivery system, the consumable comprising the composition, and a non-combustible substance delivery system which is a non-combustible aerosol provision system, or an aerosol-free delivery system.Background
[0002] Smoking articles such as cigarettes, cigars, and the like, burn tobacco during use to create tobacco smoke. Alternatives to these types of articles release an inhalable aerosol or vapour by releasing compounds from a substrate material by heating without burning. These may be referred to as non-combustible smoking articles, aerosol-generating assemblies, or non-combustible aerosol provision systems. One example of such a product is a heating device which releases compounds by heating, but not burning, a solid aerosolisable material. This solid aerosolisable material may, in some cases, contain a tobacco material. The heating volatilises at least one component of the material, typically forming an inhalable aerosol. These products may be referred to as heat-not-burn devices, tobacco heating devices or tobacco heating products. Various different arrangements for volatilising at least one component of the solid aerosolisable material are known.
[0003] As another example, there are e-cigarette / tobacco heating product hybrid devices, also known as electronic tobacco hybrid devices. These hybrid devices contain a liquid source, which may or may not contain nicotine, which is vaporised by heating to produce an inhalable vapour or aerosol. The device additionally contains a solid aerosolisable material, which may or may not contain a tobacco material, and components of this material are entrained in the inhalable vapour or aerosol to produce the inhaled medium. A further alternative is vapour products which are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, commonly known as vapour.
[0004] The compositions used in heated products and vaping platforms, can also be used in oral products which are consumed by the user.Summary
[0005] In accordance with some aspects of the invention described herein, there is provided a composition for a substance delivery system to provide a tobacco aroma, the composition comprising at least two diterpenoids derivable from a Nicotiana species, optionally wherein the total amount of diterpenoids in the composition is at least about 45 μg / g.
[0006] In some examples, the composition comprises at least three diterpenoids derivable from a Nicotiana species, at least four diterpenoids derivable from a Nicotiana species, or at least five diterpenoids derivable from a Nicotiana species.
[0007] In some examples, at least one diterpenoid is selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, a cembrane diterpenoid, and a labdane diterpenoid.
[0008] In some examples, the cembrane diterpenoid is selected from the group consisting of cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, sclareol acetate, incensole, and incensole acetate, and / or wherein the labdane diterpenoid is selected from the group consisting of abienol, abienol acetate, labdenediol, and labdenediol acetate.
[0009] In some examples, the total amount of diterpenoids in the composition is at least about 100 μg / g, at least about 200 μg / g, or at least about 500 μg / g.
[0010] In some examples, at least one diterpenoid is cembrene or2,7,11-cembratriene-4,6-diol.
[0011] In some examples, cembrene or2,7,11-cembratriene-4,6-diol is the major diterpenoid present in the composition.
[0012] In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 0.4:1 to about 3.5:1.
[0013] In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of at least about 20 μg / g.
[0014] In some examples, the composition further comprises nicotine.
[0015] In accordance with some aspects described herein, there is provided a composition for a substance delivery system, the composition comprising nicotyrine and at least onecomponent selected from the group consisting of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, or anatabine.
[0016] In some examples, the at least one component is present in a total amount of at least about 250 μg / g.
[0017] In some examples, the weight ratio of nicotyrine to the total amount of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, and anatabine present in the composition is from about 1:10 to about 1:50.
[0018] In some examples, the composition further comprises nicotine. In some examples, the weight ratio of nicotine to the total amount of nicotyrine, myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, and anatabine present in the composition is from about 5:1 to about 50:1.
[0019] In some examples, the composition further comprises one or more components selected from: C6 to C18 substituted pyrazines, C6 to C18 substituted pyridines, sesquiterpenes, terpene alcohols, C3 to C24 carboxylic acids, C7 to C18 aromatic alcohols, C3 to C24 aliphatic esters, C7 to C18 aromatic esters, C4 to C18 lactones, phenol, C7 to C18 substituted phenols, norisoprenoids, bipyridine compounds, carboxylate esters, ethers, ketones or combinations thereof.
[0020] In some examples, at least one of the diterpenoids, nicotyrine, or components present is obtained by extraction from a tobacco source.
[0021] In some examples, the composition further comprises at least one tobacco extract.
[0022] In accordance with some aspects described herein, there is provided a method for forming the composition as defined herein, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the compounds from the tobacco into the solvent.
[0023] In accordance with some aspects described herein, there is provided a consumable comprising the composition as defined herein, and a substrate material, optionally wherein the substrate material comprises a carrier material, a porous material, or a combination thereof.
[0024] In accordance with some aspects described herein, there is provided a container or package containing the composition as defined herein, preferably wherein the container orpackage is a pouched oral product comprising a saliva permeable pouch, or a cartridge for an aerosol provision system.
[0025] In accordance with some aspects described herein, there is provided a substance delivery system comprising the consumable as defined herein, or the container or package as defined herein.
[0026] In some examples, the system is a non-combustible aerosol provision system, or an aerosol-free delivery system.
[0027] In accordance with some aspects described herein, there is provided an aerosolised formulation obtainable by aerosolising the composition as defined herein or the consumable as defined herein.
[0028] These and other features, aspects and advantages of the disclosure will be apparent from the following detailed description and drawings. The invention includes any combination of two, three, four, or more of the above-noted examples as well as combinations of any two, three, four, or more features or elements set forth in this disclosure, regardless of whether such features or elements are expressly combined in a specific example description herein. This disclosure is intended to be read holistically such that any separable features or elements of the disclosed invention, in any of its various aspects and examples, should be viewed as intended to be combinable unless the context clearly dictates otherwise.Detailed Description
[0029] It is to be understood that this disclosure is not limited to the particular configurations, process steps, and materials disclosed herein as such configurations, process steps, and materials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of describing particular embodiments only and is not intended to be limiting since the scope will be limited only by the appended claims and equivalents thereof.
[0030] As used in this specification and the claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Reference to "dry % by weight" or "dry weight basis" refers to weight on the basis of dry ingredients (i.e., all ingredients except water or carrier). Reference to "wet weight" refers to the weight of the formulation or composition including water or carrier. Unless otherwise indicated, reference to "% by weight" (or “% by weight”) of formulation or composition reflects the total wet weight of the formulation or composition (i.e., including water / carrier).
[0031] In this specification, unless otherwise stated, the term "about" modifying the quantity of an ingredient in the formulation or employed in the methods refers to variation in the numerical quantity that can occur, for example, through typical measuring and liquid handling procedures used for making concentrates or use solutions in the real world; through inadvertent error in these procedures; through differences in the manufacture, source, or purity of the ingredients employed to make the formulation, or to carry out the methods; and the like. The term “about” also encompasses amounts that differ due to different equilibrium conditions for a formulation or composition resulting from a particular initial mixture. Whether or not modified by the term "about", the claims include equivalents to the quantities.
[0032] A cigarette, also known as a factory-made cigarette or ‘FMC’, gives rise to a cigarettelike or FMC-like experience when smoked by a consumer. Such an experience can have various dimensions, including sense, taste and flavour dimensions. By the ‘sense’ of a cigarette, is meant the overall feel of smoking a cigarette which includes attributes such as impact, irritation, harshness, mouth drying, and mouth coating or mouthfeel. By the “taste” of a cigarette is meant the overall taste of smoking a cigarette including hay-like, bread-like, smoky, tannin, resinous, musk, etc., and by the “flavour” of a cigarette is meant the overall flavour of smoking cigarette such as creamy, fruity, floral, green, spicy, savoury, roasted, woody, etc.
[0033] As noted above, there are several alternative means by which a consumer can replicate the smoking experience. These include e-cigarettes and tobacco heating devices which provide the consumer with an inhalable aerosol. One potential drawback with such devices is, however, that they may fail to completely replicate one or more of the dimensions associated with the FMC-like experience. One dimension that is particularly critical for consumers is “flavour”. With an inhalable aerosol, flavour is delivered primarily via aroma. Hence, when a consumer is seeking an “FMC-like experience” with a heating device (whether with a solid, liquid, gel or hybrid aerosolisable formulation(s)), it is desirable for the aroma to replicate that of smoking a cigarette, i.e. for the aroma to be tobacco-like and deliver a richness and complexity comparable to smoking a cigarette.
[0034] The present disclosure relates to a combination of ingredients which can be used in a consumable for a substance delivery system to replicate the ‘FMC’ flavour. In particular, the inventors have identified a range of compounds that are believed to be responsible for providing a tobacco-like aroma and delivering the desired ‘FMC-like’ flavour experience when employed in a non-combustible substance delivery system. These compounds were identified by collecting and analysing a range of different tobacco extracts, as well as using machine learning and / or human sensory assessment. More information on the analysis is set out herein.
[0035] The compounds of the present disclosure can advantageously be used to prepare a composition for inclusion in a consumable for a substance delivery system, including a composition which can be used with or without a tobacco extract in order to replicate the ‘FMC’ flavour experience. Furthermore, the levels of the compounds can be adjusted in order to tailor the level of authenticity to consumer preference or the substrate material (for example, the tobacco-type from which the base extract was derived).
[0036] The present disclosure is particularly focussed on a combination of components that impart a desired flavour or aroma attribute to provide an ‘FMC-like’ experience when employed in a substance delivery system. The compounds identified for such an FMC-like experience may be selected from at least two diterpenoids derivable from a Nicotiana species or nicotyrine and at least one component selected from the group consisting of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, or anatabine.
[0037] The inventors have therefore found a combination of components that are able to provide a tobacco aroma when used in a substance delivery system, without the need to smoke or burn a cigarette. This includes the ability to combine the combination of components with a substrate material, such as a tobacco or other plant extract, and thereby improve the ‘FMC-like’ flavour profile of the substrate material. Furthermore, it is possible to create a composition for use in an aerosol-free delivery system, such as an oral product which is placed in the oral cavity of the consumer. This may allow for a more user-friendly and improved cigarette-like experience to be created. Several benefits are therefore associated with the composition of the present disclosure; many consumers who smoke traditional cigarettes may previously have been reluctant or unwilling to use non-combustible aerosol provision devices, e.g. heat-not-burn, hybrid or vapour devices, or oral compositions, because the experience of using these devices or compositions may differ from the experience of burning and smoking a cigarette. The composition of the present disclosure may, however, allow for consumers to get the same or similar experience to smoking a cigarette when using oral compositions and / or noncombustible aerosol provision systems. For example, when using the composition of the present disclosure in a non-combustible aerosol provision system, a more ‘cigarette-like’ experience and / or aerosol can be created compared to using a previously-known or commercially available composition for use in such devices. In this respect, it will be understood that the substance delivery system is not a combustible substance delivery system (e.g. a cigarette). Hence, the term “substance delivery system” in the present disclosure means non-combustible substance delivery system.
[0038] For ease of reference, these and further aspects of the present invention are now discussed under appropriate section headings. However, the teachings under each section are not necessarily limited to each particular section. In other words, particular sections of the description are not to be read in isolation from other sections.
[0039] The ranges provided herein relate to preferred amounts of each of the components. Each of these ranges may be taken alone or combined with one or more other component range(s) to provide a preferred embodiment of the invention.Composition for use in a substance delivery system
[0040] There is provided herein a composition for use in a substance delivery system to provide a tobacco aroma (flavour) and thereby replicate the desired ‘FMC-like’ experience for a consumer. By the term “tobacco aroma” is meant an aroma that simulates the aroma from burning or smoking a cigarette containing tobacco. This aroma results from various volatile compounds naturally-present in the tobacco and / or produced during curing, aging and / or processing of the tobacco leaves. Many of the compounds present in the composition of the present disclosure thus have a boiling point of less than 250°C and / or a molecular weight of about 50 to about 500 g / mol. The molecular weight is the ratio of the mass of a molecule to the unified atomic mass unit (as defined in the IUPAC Gold Book); it is also referred to in the art as the relative molar mass. Hence, the compounds present in the composition of the present disclosure have the potential to be aerosolised when the composition is used in a substance delivery system which is a non-combustible aerosol provision system or device, such as a heat-not-burn or vaping device or system.
[0041] This composition may be used in a substance delivery system with or without a plant (e.g. tobacco) material. When used in combination with a tobacco material such as a tobacco extract, the extract may first be analysed for the presence of one or more of the compounds, and then supplemented with one or more compounds as disclosed herein in order to improve the FMC-like flavour and / or sensation experience obtained when used in a substance delivery system. That is, one or more of the compounds disclosed herein may be added to a tobacco extract, the tobacco extract optionally already containing one or more of the compounds disclosed herein. It is also possible to add further components to the compositions which may be absent from a tobacco extract. For example, some components may be absence from the tobacco extract, but present in smoke formed by burning the same tobacco used to form the extract, e.g. in a cigarette. Some components may also, or alternatively, be absent from the tobacco extract, but present in aerosol formed by aerosolising the extract, by heat or another means such as mechanical aerosolisation. In further examples, the components may modify the overall profile of compounds present in the tobacco extract in a way that achieves a moreFMC-like experience, and / or steer the overall profile towards a specific variety or blend of tobacco. This may, in some examples, further improve the cigarette-like experience provided by the composition of the present disclosure when used in a substance delivery system.Diterpenoids
[0042] In accordance with an aspect of the present disclosure, there is provided a composition for a substance delivery system to provide a tobacco aroma, the composition comprising at least two diterpenoids derivable from a Nicotiana species, optionally wherein the total amount of diterpenoids in the composition is at least about 45 μg / g.
[0043] In some examples, the composition comprises at least three diterpenoids derivable from a Nicotiana species. In some examples, the composition comprises at least four diterpenoids derivable from a Nicotiana species. In some examples, the composition comprises at least five diterpenoids derivable from a Nicotiana species.
[0044] In some examples, the composition is not raw tobacco. As used herein the term “raw tobacco” refers to any part of a plant of the Nicotiana species (e.g. leaf or stem) that has been harvested from the ground but not otherwise subjected to any processing steps.
[0045] As used herein the term “diterpenoids derivable from a Nicotiana species” refers to diterpenoids that naturally exist in a plant of the Nicotiana species.
[0046] In some examples, the at least two diterpenoids are derivable from a Nicotiana species selected from N. tabacum, N. rustica, N. alata, N. arentsii, N. excelsior, N. forgetiana, N. glauca, N. glutinosa, N. gossei, N. kawakamii, N. knightiana, N. langsdorffi, N. otophora, N. setchelli, N. sylvestris, N. tomentosa, N. tomentosiformis, N. undulata, N. x sanderae, N. africana, N. amplexicaulis, N. benavidesii, N. bonariensis, N. debneyi, N. longiflora, N. maritima, N. megalosiphon, N. occidentalis, N. paniculata, N. plumbaginifolia, N. raimondii, N. rosulata, N. simulans, N. stocktonii, N. suaveolens, N. umbratica, N. velutina, N. wigandioides, N. acaulis, N. acuminata, N. attenuata, N. benthamiana, N. cavicola, N. clevelandii, N. cordifolia, N. corymbosa, N. fragrans, N. goodspeedii, N. linearis, N. miersii, N. nudicaulis, N. obtusifolia, N. occidentalis subsp. Hersperis, N. pauciflora, N. petunioides, N. quadrivalvis, N. repanda, N. rotundifolia, N. solanifolia, N. spegazzinii, and combinations thereof.
[0047] As used herein, the term “diterpenoid” refers to a compound derived from a diterpene skeleton comprising approximately 20 carbon atoms formed from four isoprene units, including functionalised, rearranged, cyclised, or otherwise modified derivatives thereof. Suitable diterpenoids in this regard include, but are not limited to, those from the diterpenoid class of cembranes, the diterpenoid class of labdanes, neophytadiene, phytane, phytol, isophytol,geranyl linalool, kaurenal, and farnesyl acetone. Cembrane diterpenoids comprise the following carbon skeleton:Cembrane diterpenoids include cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole, and incensole acetate. Labdane diterpenoids comprise the following carbon skeleton:Labdane diterpenoids include abienol, abienol acetate, labdenediol, and labdenediol acetate.
[0048] In some examples, at least one diterpenoid is selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, cembrene, sclareol, sclareol acetate, 2,7,11-cembratriene-4,6-diol, incensole, incensole acetate, abienol, abienol acetate, labdenediol, and labdenediol acetate. In all aspects of the present disclosure, the disclosure includes, where appropriate, all enantiomers, tautomers, stereoisomers and geometric isomers of the compounds disclosed herein, as appropriate. Hence, where one enantiomer, tautomer, stereoisomer and / or geometric isomer is depicted or referenced herein, this is not to be construed as limiting.
[0049] Without wishing to be bound by theory, it is believed that the presence of at least two diterpenoids derivable from a Nicotiana species contributes a darkness (e.g. having more complexity, depth and / or aromaticity) and richness to the flavour profile, which improves the complexity of the tobacco aroma and so creates a more FMC-like experience when the composition is used in a substance delivery system. Further, these compounds can contribute to other FMC-like attributes including sensory attributes such as mouth feel. Hence, by formulating a composition according to the present disclosure, it is possible to formulate a composition which is able to simulate a cigarette-like flavour and / or aroma experience when used in a substance delivery system.
[0050] In some examples, the composition comprises at least three diterpenoids selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, cembrene, sclareol, sclareol acetate, 2,7,11-cembratriene-4,6-diol, incensole, incensole acetate, abienol, abienol acetate, labdenediol, and labdenediol acetate. In some examples, the composition comprises at least four diterpenoids selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, cembrene, sclareol, sclareol acetate, 2,7,11-cembratriene-4,6-diol, incensole, incensole acetate, abienol, abienol acetate, labdenediol, and labdenediol acetate. In some examples, the composition comprises at least five diterpenoids selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, cembrene, sclareol, sclareol acetate, 2,7,11-cembratriene-4,6-diol, incensole, incensole acetate, abienol, abienol acetate, labdenediol, and labdenediol acetate. In some examples, the composition comprises all of the diterpenoids selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, cembrene, sclareol, sclareol acetate, 2,7,11-cembratriene-4,6-diol, incensole, incensole acetate, abienol, abienol acetate, labdenediol, and labdenediol acetate.
[0051] In some examples, at least one diterpenoid is selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol.
[0052] In some examples, at least one diterpenoid is cembrene or 2,7,11-cembratriene-4,6-diol.
[0053] In some examples, the composition comprises cembrene, neophytadiene, sclareol, and geranyl linalool.
[0054] In some examples, the composition comprises cembrene, neophytadiene, kaurenal, sclareol, and incensole acetate.
[0055] In some examples, the composition comprises cembrene, neophytadiene, phytol, isophytol, sclareol, and 2,7,11-cembratriene-4,6-diol.
[0056] In some examples, the composition comprises cembrene, neophytadiene, phytane, phytol, geranyl linalool, and 2,7,11-cembratriene-4,6-diol.
[0057] In some examples, the composition comprises neophytadiene, phytol, geranyl linalool, and 2,7,11-cembratriene-4,6-diol.
[0058] In some examples, the composition comprises neophytadiene, geranyl linalool, and 2,7,11-cembratriene-4,6-diol.
[0059] In some examples, the composition comprises neophytadiene, and 2,7,11-cembratriene-4,6-diol.
[0060] In some examples, the composition comprises farnesyl acetone, 2,7,11-cembratriene-4,6-diol, labdenediol, and abienol.
[0061] In some examples, the composition comprises 2,7,11-cembratriene-4,6-diol, labdenediol, and abienol.
[0062] In some examples, the composition comprises farnesyl acetone and 2,7,11-cembratriene-4,6-diol.
[0063] In some examples, the total amount of diterpenoids in the composition is at least about 45 μg / g. In some examples, the total amount of diterpenoids in the composition is at least about 100 pg / g. In some examples, the total amount of diterpenoids in the composition is at least about 200 pg / g. In some examples, the total amount of diterpenoids in the composition is at least about 500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of diterpenoids of at least about 0.00045 wt%, or at least 0.001 wt%, or at least 0.002 wt%, or at least 0.005 wt%.
[0064] In some examples, the total amount of diterpenoids in the composition is from about 45 pg / g to about 2000 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 100 pg / g to about 2000 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 500 pg / g to about 2000 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of diterpenoids of from about 0.00045 wt% to about 0.02 wt%, or from about 0.001 wt% to about 0.02 wt%, or from about 0.005 wt% to about 0.02 wt%.
[0065] In some examples, the total amount of diterpenoids in the composition is from about 45 pg / g to about 1000 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 45 pg / g to about 750 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 45 pg / g to about 500 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 45 pg / g to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of diterpenoids of from about 0.00045 wt% to about 0.01 wt%, or from about 0.00045 wt% to about 0.0075 wt%, or from about 0.00045 wt% to about 0.005 wt%, or from about 0.00045 wt% to about 0.003 wt%.
[0066] In some examples, the total amount of diterpenoids in the composition is from about 100 pg / g to about 750 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 100 pg / g to about 500 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 100 pg / g to about 300 pg / g. In some examples, the total amount of diterpenoids in the composition is from about 200 pg / g to about 300 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of diterpenoids of from about 0.001 wt% to about 0.0075 wt%, or from about 0.001 wt% to about 0.005 wt%, or from about 0.001 wt% to about 0.003 wt%, or from about 0.002 wt% to about 0.003 wt%.
[0067] In some examples, a cembrane diterpenoid is the major diterpenoid present in the composition. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is the major diterpenoid present in the composition. In some examples, 2,7,11-cembratriene-4,6-diol is the major diterpenoid present in the composition. As used herein, the term “major diterpenoid” refers to the diterpenoid that is present in the highest amount by weight in the composition compared with the amount by weight of any other diterpenoids present in the composition.
[0068] In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediolin the composition is from about 0.4:1 to about 3.5:1. In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 1:1 to about 3.5:1. In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 1.5:1 to about 3.5:1.
[0069] In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 0.4:1 to about 3:1. In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 0.4:1 to about 2.5:1. In some examples, the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 0.4:1 to about 2:1.
[0070] In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of at least about 20 μg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of at least about 50 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of at least about 100 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of at least about 500 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of at least about 700 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise cembrene or 2,7,11-cembratriene-4,6-diol in amount of at least about 0.0002 wt%, or at least about 0.0005 wt%, or at least about 0.001 wt%, or at least about 0.005 wt%, or at least about 0.007 wt%.
[0071] In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 20 pg / g to about 1200 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 20 pg / g to about 1000 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 20 pg / g to about 700 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 20 pg / g to about 500 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 20 pg / g to about 200 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise cembrene or 2,7,11-cembratriene-4,6-diol in amount of from about 0.0002 wt% to about 0.012 wt%, or from about 0.0002 wt% to about 0.01 wt%, or from about 0.0002 wt% to about 0.007 wt%, or from about 0.0002 wt% to about 0.005 wt%, or from about 0.0002 wt% to about 0.002 wt%.
[0072] In some examples, cembrene or2,7,11-cembratriene-4,6-diol is present in an amount of from about 50 pg / g to about 1200 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 100 pg / g to about 1200 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 200 pg / g to about 1200 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 500 pg / g to about 1200 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise cembrene or 2,7,11-cembratriene-4,6-diol in amount of from about 0.0005 wt% to about 0.012 wt%, or from about 0.001 wt% to about 0.012 wt%, or from about 0.002 wt% to about 0.012 wt%, or from about 0.005 wt% to about 0.012 wt%.
[0073] In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 30 pg / g to about 1000 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 50 pg / g to about 700 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 50 pg / g to about 500 pg / g. In some examples, cembrene or 2,7,11-cembratriene-4,6-diol is present in an amount of from about 50 pg / g to about 200 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable.In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise cembrene or 2,7,11-cembratriene-4,6-diol in amount of from about 0.0003 wt% to about 0.01 wt%, or from about 0.0005 wt% to about 0.007 wt%, or from about 0.0005 wt% to about 0.005 wt%, or from about 0.0005 wt% to about 0.002 wt%.
[0074] In some examples, the composition further comprises nicotine. In some examples, the amount of nicotine in the composition is at least about 100 pg / g. In some examples, the amount of nicotine in the composition is at least about 250 μg / g. In some examples, the amount of nicotine in the composition is at least about 500 pg / g. In some examples, the amount of nicotine in the composition is at least about 1000 pg / g. In some examples, the amount of nicotine in the composition is at least about 3000 pg / g.
[0075] In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 60 000 pg / g. In some examples, the amount of nicotine in the composition is from about 250 pg / g to about 30 000 pg / g. In some examples, the amount of nicotine in the composition is from about 500 pg / g to about 10 000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 5000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 3500 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 2000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 1000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 500 pg / g.
[0076] In some examples, the amount of nicotine in the composition is from about 400 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 600 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 1000 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 3000 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 4000 pg / g to about 6000 pg / g.
[0077] In some examples, the amount of nicotine in the composition is from about 300 pg / g to about 5000 pg / g. In some examples, the amount of nicotine in the composition is from about 400 pg / g to about 4000 pg / g. In some examples, the amount of nicotine in the composition is from about 400 pg / g to about 2000 pg / g.Alkaloids
[0078] In another aspect according to the present disclosure, there is provided a composition for a substance delivery system, the composition comprising nicotyrine and at least one component selected from the group consisting of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, or anatabine. Such compounds are referred to herein as “Group A”.
[0079] Without wishing to be bound by theory, it is believed that the presence of nicotyrine and at least one component selected from Group A contributes to an authentic cigarette-like aroma experience that is not usually achievable in compositions for non-combustible aerosol provision devices. Hence, by formulating a composition according to the present disclosure, it is possible to formulate a composition which is able to simulate a cigarette-like aroma experience when used in a substance delivery system.
[0080] In some examples, the at least one component includes cotinine.
[0081] In some examples, the at least one component includes anabasine, anatabine, myosmine, and nornicotine.
[0082] In some examples, the composition comprises nicotyrine, cotinine, n'-propylnornicotine, nicotine-1'-N-oxide, and caffeine.
[0083] In some examples, the composition comprises nicotyrine and cotinine.
[0084] In some examples, the composition comprises nicotyrine, cotinine, myosmine, nicotine-1'-N-oxide, and trigonelline.
[0085] In some examples, the composition comprises nicotyrine, cotinine, myosmine, and nicotine-1'-N-oxide.
[0086] In some examples, the total amount of the at least one component selected from Group A in the composition is at least about 2 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is at least about 5 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is at least about 10 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is at least about 20 μg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is at least about 50 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is at least about 100 pg / g. In someexamples, the total amount of the at least one component selected from Group A in the composition is at least about 250 μg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of the at least one component selected from Group A of at least about 0.00002 wt%, or at least about 0.00005 wt%, or at least about 0.0001 wt%, or at least about 0.0002 wt%, or at least about 0.0005 wt%, or at least about 0.001 wt%, or at least about 0.0025 wt%.
[0087] In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 50000 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 25 000 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 10 000 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 1500 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 1000 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 500 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 100 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 2 pg / g to about 50 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of the at least one component selected from Group A of from about 0.00002 wt% to about 0.015 wt%, or from about 0.00002 wt% to about 0.01 wt%, or from about 0.00002 wt% to about 0.005 wt%, or from about 0.00002 wt% to about 0.001 wt%, from about 0.00002 wt% to about 0.0005 wt%.
[0088] In some examples, the total amount of the at least one component selected from Group A in the composition is from about 5 pg / g to about 1500 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 10 pg / g to about 1500 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 50 pg / g to about 1500 pg / g. In some examples, the total amount of the at least one component selected from GroupA in the composition is from about 100 pg / g to about 1500 pg / g. In some examples, the total amount of the at least one component selected from Group A in the composition is from about 200 pg / g to about 1500 pg / g. When incorporated into a consumable, the composition may be present at about 5% w / w to about 30% w / w meaning that these amounts will be adjusted accordingly based on the total weight of the consumable. In some examples, the composition may be present at about 5% w / w to about 20% w / w. In some examples, the composition may be present at about 5% w / w to about 15% w / w. For example, at an inclusion level of 10% w / w of the composition, the consumable may comprise a total amount of the at least one component selected from Group A of from about 0.00005 wt% to about 0.015 wt%, or from about 0.0001 wt% to about 0.015 wt%, or from about 0.0005 wt% to about 0.015 wt%, or from about 0.001 wt% to about 0.015 wt%, from about 0.002 wt% to about 0.015 wt%.
[0089] In some examples, the amount of anabasine in the composition is from about 100 pg / g to about 10000 pg / g. In some examples, the amount of anabasine in the composition is from about 250 pg / g to about 5000 pg / g. In some examples, the amount of anabasine in the composition is from about 500 pg / g to about 2500 pg / g.
[0090] In some examples, the amount of anatabine in the composition is from about 100 pg / g to about 10000 pg / g. In some examples, the amount of anatabine in the composition is from about 250 pg / g to about 5 000 pg / g. In some examples, the amount of anatabine in the composition is from about 500 pg / g to about 2500 pg / g.
[0091] In some examples, the amount of myosomine in the composition is from about 100 pg / g to about 10000 pg / g. In some examples, the amount of myosomine in the composition is from about 250 pg / g to about 5000 pg / g. In some examples, the amount of myosomine in the composition is from about 500 pg / g to about 2500 pg / g.
[0092] In some examples, the amount of nornicotine in the composition is from about 100 pg / g to about 10000 pg / g. In some examples, the amount of nornicotine in the composition is from about 250 pg / g to about 5000 pg / g. In some examples, the amount of nornicotine in the composition is from about 500 pg / g to about 2500 pg / g.
[0093] In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:0.5 to about 1:50. In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:1 to about 1:50. In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:10 to about 1:50. In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:20 to about1:50. In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:20 to about 1:40.
[0094] In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:0.5 to about 1:40. In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:0.5 to about 1:35. In some examples, the weight ratio of nicotyrine to the total amount of components selected from Group A is from about 1:0.5 to about 1:30.
[0095] In some examples, the composition further comprises nicotine. In some examples, the amount of nicotine in the composition is at least about 100 pg / g. In some examples, the amount of nicotine in the composition is at least about 250 μg / g. In some examples, the amount of nicotine in the composition is at least about 500 pg / g. In some examples, the amount of nicotine in the composition is at least about 1000 pg / g. In some examples, the amount of nicotine in the composition is at least about 3000 pg / g.
[0096] In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 5000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 3500 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 2000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 1000 pg / g. In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 500 pg / g.
[0097] In some examples, the amount of nicotine in the composition is from about 400 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 600 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 1000 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 3000 pg / g to about 6000 pg / g. In some examples, the amount of nicotine in the composition is from about 4000 pg / g to about 6000 pg / g.
[0098] In some examples, the amount of nicotine in the composition is from about 300 pg / g to about 5000 pg / g. In some examples, the amount of nicotine in the composition is from about 400 pg / g to about 4000 pg / g. In some examples, the amount of nicotine in the composition is from about 400 pg / g to about 2000 pg / g.
[0099] In some examples, the amount of nicotine in the composition is from about 100 pg / g to about 60 000 pg / g. In some examples, the amount of nicotine in the composition is fromabout 250 pg / g to about 30 000 pg / g. In some examples, the amount of nicotine in the composition is from about 500 pg / g to about 10000 pg / g.[000100] In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 5:1 to about 2000:1. In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 5:1 to about 350:1. In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 5:1 to about 50:1. In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 5:1 to about 30:1. In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 5: 1 to about 10: 1.[000101] In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 10:1 to about 2000:1. In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 20:1 to about 2000: 1. In some examples, the weight ratio of nicotine to the total amount of components selected from Group A is from about 30:1 to about 2000:1.Plant Extracts[000102] In some examples, one or more of the compounds are obtained by extraction from a natural source, e.g. a tobacco source. Also provided herein is a method for forming the composition, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the compounds from the tobacco into the solvent.[000103] The present disclosure is not, however, limited to obtaining one or more compounds via an extraction method. The present disclosure includes the formulation of a partially or totally synthetic or artificial composition. In some examples, at least one of the compounds may be a synthetic compound. In this manner, the composition may include one or more compounds which are naturally derived, e.g. from a tobacco source, and one or more compounds which are synthetic (e.g. obtained commercially or otherwise synthesised).[000104] In some examples, the total number of chemical compounds present in the composition is less than about 800, such as less than about 600, or less than about 500. By total number of chemical compounds is meant the number of different chemical compounds present at a detectable level by e.g. GC-MS.[000105] In some examples, the total content of any one of the tobacco-specific nitrosamines (TSNAs) in the composition, namely N-nitrosonornicotine (NNN), N’-nitrosoanatabine (NAT), N-nitrosoanabasine (NAB) and nicotine-derived nitrosamine ketone (NNK), is less than about4 pg / g, or less than about 3 pg / g. This may be an indication that at least one compound is obtained from a tobacco extract.[000106] In some examples, the composition may include formaldehyde and / or acetaldehyde. This may be an indication that at least one compound is obtained from a tobacco extract. The amount of formaldehyde and / or acetaldehyde is less than about 4 pg / g.[000107] In some examples, the composition may include at least one plant material, optionally wherein the plant material is a tobacco extract. The tobacco extract may include one or more of the compounds defined above for the composition. The disclosures made herein in relation to the compounds thus apply equally to a tobacco extract comprising one or more of said compounds. In other examples, one or more of said compounds may be added to the tobacco extract to form a composition of the present disclosure. In some examples, the composition is a tobacco extract.[000108] When present or used to obtain one or more compounds of the composition, any tobacco extract may be used. In some examples, the tobacco extract may be an extract of Virginia tobacco, Burley tobacco, Oriental tobacco, or a combination thereof. In some examples, the tobacco extract comprises an extract of Virginia tobacco. The tobacco may be cured; in some examples, the tobacco is cured. Cured tobacco may be flue-cured, air-cured and / or sun-cured. In some examples, the tobacco extract comprises an extract of flue-cured Virginia tobacco.[000109] In some examples, the tobacco from which one or more compounds may be extracted (referred to herein as raw tobacco) may include tobacco leaf. In some examples, the tobacco leaf may be defined by its nicotine content. In some examples, the nicotine content of the tobacco leaf may be from about 0.5 to about 8.0 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 0.8 to about 7.5 wt%, based on the total weight of the leaf. In some examples, the nicotine content of the tobacco leaf may be from about 1.5 to about 7.5 wt%, based on the total weight of the leaf.[000110] In some examples, the tobacco leaf may be defined by its sugar content. Exemplary nicotine and sugar contents for flue-cured Virginia tobacco are about 0.9 to about 5.5 wt% nicotine and about 4 to about 25 wt% sugar. Exemplary nicotine and sugar contents for aircured Burley tobacco are about 1.5 to about 6.5 wt% nicotine and less than about 1 to about 2 wt% sugar. Exemplary nicotine and sugar contents for sun-cured Oriental tobacco are about 0.5 to about 3.0 wt% nicotine and about 8 to about 12 wt% sugar. Exemplary nicotine and sugar contents for fire-cured dark tobacco are about 2.5 to about 6 wt% nicotine and less than about 1 to about 2 wt% sugar.[000111] In some examples, the tobacco extract is obtained from cured Virginia tobacco, cured Burley tobacco, cured Oriental tobacco, or a combination thereof. In some examples, the tobacco extract is obtained from flue-cured Virginia tobacco, air-cured Burley tobacco, sun-cured oriental tobacco, or a combination thereof.[000112] The solvent extraction method disclosed herein for forming the composition is not particularly limited. It may be a simultaneous distillation extraction method, a supercritical fluid extraction method or a combination thereof. Other extraction methods are also known including maceration or percolation or hot reflux or Soxhlet extraction, or microwave extraction. The method may also include further steps such as filtration, fractionation, pyrolysis, adsorption, distillation and / or purification. Extraction methods are provided in WO 2026 / 021165 A1, US 2026 / 0053181 A1, WO 2026 / 026620 A1, WO 2026 / 045589 A1, and WO 2026 / 045587 A1 which are herein incorporated by reference for such methods.[000113] Hot reflux and microwave extraction are described in WO 2026 / 045589 A1 and WO 2026 / 045587 A1 (Shenzhen Smoore Technology LTD), which are herein incorporated by reference for such methods. For example, a hot reflux extraction method is disclosed using an SF-2L small-scale reflux apparatus. In this method, tobacco leaves are placed in a roundbottom flask which is heated by an electric heating mantle. Evaporated ethanol and water are passed into a condenser and refluxed. The extraction temperature is 95°C and the extraction time is 120 minutes. After extraction, a filtrate is collected and the extract is concentrated using a rotary evaporator. Further examples of hot reflux extraction can be found in WO 2026 / 045587 A1.[000114] Simultaneous distillation extraction is a technique in which the steps of isolation and extraction of certain compounds from a sample can be achieved simultaneously. In some example, a simultaneous distillation extraction (SDE) process can be used for forming tobacco extracts in which process comprises (i) providing a tobacco material, (ii) subjecting the tobacco material to steam distillation, and (iii) extracting one or more volatile compounds of interest from the tobacco material with a solvent, wherein the distillation step (ii) and extraction step (iii) are carried out simultaneously.[000115] The method may comprise mixing a quantity of tobacco (e.g. ground tobacco) with water. This solution may have a pH of from about 5 to about 7, such as from about 5.5 to about 6.5. Glass beads may be added to prevent bumping. The solution may then be heated, for example, to a temperature of from about 100°C to about 130°C.[000116] The distillation step (ii) and extraction step (iii) being carried out simultaneously means that in some examples, the SDE method may be carried out in a single step. In someexamples, an additional distillation and / or extraction step is excluded. In some examples, the SDE method is carried out in a single apparatus with no additional processing prior to removal of the extracted product from the apparatus.[000117] In some examples the solvent used for extraction is a non-polar solvent. In some examples the solvent used for extraction is a polar solvent. As used herein, the term “polar” refers to a solvent having a dielectric constant of greater than or equal to 15. As used herein, the term “non-polar” refers to a solvent having a dielectric constant of less than 15.[000118] In some examples, the solvent is immiscible with water. In some examples, the solvent comprises an organic solvent. The term “organic” is understood in the art; it is typically considered to be a solvent comprising carbon. In some examples, the solvent is selected from: n-butanol, cyclohexane, dichloromethane, ethyl acetate, heptane, hexane, methyl-t-butyl ether, 2-butanone, pentane, diisopropyl ether, diethyl ether, and mixtures thereof. The use of a mixture of pentane and ether is non-toxic and may be easily replaced by ethanol after extraction of the volatile compounds of interest has been achieved.[000119] In some examples, further processing of the extracted product may be carried out. The further processing may comprise a purifying step which comprises replacing the solvent used for extraction with another solvent suitable for use in a composition as described herein. In some examples, such a purifying step comprises replacing the solvent used for extraction with ethanol.[000120] In some examples a supercritical fluid extraction (SFE) process used for forming tobacco extracts is employed. The process may comprise contacting tobacco with an extraction solvent under supercritical conditions. In some examples, the extraction solvent comprises, or is, supercritical carbon dioxide. In some examples, no co-solvent is present.[000121] In some examples, the SFE process is performed at a pressure of from about 50 to about 500 bar. In some examples, the temperature during extraction may range from about 25°C to about 90°C. In some examples, supercritical extraction is performed using a flow rate of extraction solvent of from about 0.5 to about 5 kg / hr. In some examples, the pressure is varied during the SFE process, for example to collect fractions having varying volatility. In such examples, a lower pressure (e.g. about 50 to about 200 bar) may be used for a first period of time, followed by a higher pressure (e.g. from about 200 to about 500 bar) for a second period of time. The first period of time may be from about 0.5 to about 2 hours. The second period of time may be from about 0.5 to about 2 hours. In some examples, the two fractions or extracts are combined. In some examples the two fractions or extracts are collected separately and notcombined. In some examples, only the extract from the second extraction is retained and / or used in the present disclosure.[000122] In some examples, the SFE process involves placing ground tobacco into a vessel (e.g. 260 g of ground tobacco into a 1L vessel) and using supercritical carbon dioxide as the extraction solvent at 1 kg / h. No co-solvent may be used. The pressure of the system is set to 100 to 300 bar and the temperature maintained at 60 degrees. The extracts are collected in two containers: one for the volatile fraction, one for the non-volatile fraction. The volatile fraction is collected first, pressure at 100 bar and for a period of 1 hour. The non-volatile fraction is collected second, the pressure being increased to 300 bar and extraction conducted for a period of 1.5 hours. Only the non-volatile fraction is retained for the present disclosure.[000123] In some examples, the SFE process involves placing ground tobacco in a container (e.g., 260 g of ground tobacco in a 1 L container) and using supercritical carbon dioxide as an extraction solvent at 1 kg / h and ethanol as a co-solvent (30%). The pressure of the system is set to 250 bar and the temperature maintained at 75 degrees. The extracts are collected for a period of 2 hours.[000124] In accordance with some aspects of the present disclosure, there is provided a composition for a substance delivery system to provide a tobacco aroma, wherein the composition comprises a plant extract as defined herein, and at least two diterpenoids derivable from a Nicotiana species.[000125] In accordance with some aspects of the present disclosure, there is provided a composition for a substance delivery system to provide a tobacco aroma, wherein the composition comprises a plant extract as defined herein, and nicotyrine and at least one component selected from the group consisting of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, or anatabine[000126] The above-defined concentrations for each component apply equally to the composition comprising a plant extract. The above-defined concentrations for the total amount of the components apply equally to the composition comprising a plant extract. The abovedefined weight ratios of the components apply equally to the composition comprising a plant extract.Tobacco Particles[000127] In some examples, the composition may further comprise a plurality of solid tobacco particles. In some examples, the solid tobacco particles remain as distinct entitieswithin the composition, such that the composition can be considered to be in the form of a heterogeneous mixture. For example, the solid tobacco particles may be at least partially suspended in the composition. As used herein, the term “at least partially suspended” means that the solid tobacco particles are distributed within the composition (e.g. a liquid composition), wherein the distribution of said particles within the formulation is not necessarily even. For example, the spatial distribution of the particles may be biased towards one portion of the composition. In some examples, the suspension of the particles may be enhanced by agitation, for example shaking or inversion, such as when comprised in an article and / or in a noncombustible aerosol provision system, including in use.[000128] In some examples the solid tobacco particles are visible, for example to the naked eye. It will be understood that the term “visible” as used herein means that the solid tobacco particles can be seen, e.g. when present in a composition according to the present disclosure, such as by a user. Thus, the presence of the solid tobacco particles in the composition of the present disclosure can be readily apparent to a user (e.g. of a substance provision system), such as by the presence of distinct, visible particles in said composition. By “the naked eye”, the term will be understood to mean that the solid tobacco particles can be seen e.g. by a user without magnification or other visual enhancement. In various examples, the solid tobacco particles are visible under ambient conditions, for example normal temperature (e.g. from about 15 °C to about 25 °C) and pressure (e.g. about 1 atm). In various examples, the tobacco particles may be visible in one or more stages of use but not all. For example, the tobacco particles may be visible in the composition as such. In further examples, the tobacco particles may be visible when the composition is comprised in an article. For example, the article may be partially or completely transparent such that the presence of the tobacco particles in the formulation in the article may be determined by a user by viewing the article. In some examples, the article may comprise at least a transparent portion, wherein the transparent portion may be configured so that the solid tobacco particles are visible to the naked eye, e.g. to a user of the article. In further examples, the tobacco particles may be visible when the composition is comprised in a substance delivery system. For example, the article and substance delivery system may each comprise at least a transparent portion wherein said transparent portions are arranged such that the tobacco particles are visible to the naked eye, e.g. to a user of the substance delivery system.[000129] The size of the solid tobacco particles is not necessarily limited. In some examples, the solid tobacco particles have a size of at least about 50 pm, at least about 0.1 mm or at least about 0.5 mm. In some examples, the solid tobacco particles have a size of up to about 15 mm, up to about 10 mm or up to about 2 mm. In further examples, the solid tobaccoparticles have a size of from about 50 pm to about 15 mm, from about 0.1 mm to about 10 mm or from about 0.5 mm to about 2 mm. The particle size may be determined by sieving. For example, a recited lower particle size limit means that the particles will not pass through a sieve with a mesh size of said limit, and an upper particle size limit means that the particles will pass through a sieve with a mesh size of said limit. Thus, a particle size of at least 50 pm means that the particles are retained on a sieve with a 50 pm mesh. In another example, a particle size of up to about 15 mm means that the particles are not retained on a sieve (i.e. the particles pass through the sieve) with a 15 mm mesh.[000130] In some examples, at least about 80%, at least about 90%, at least about 95% or at least about 99% by weight of the solid tobacco particles have a size according to any of the foregoing examples.[000131] The tobacco material from which the tobacco particles according to the present disclosure are obtained or obtainable from is not necessarily limited. For example, the tobacco material may be as described in any of the examples of tobacco / tobacco material described herein. In some examples, the tobacco material from which the tobacco particles are obtained or obtainable from may include tobacco leaf. In further examples the tobacco leaf may be defined by its nicotine and / or sugar content as described herein.[000132] In some examples, the tobacco particles are obtained or obtainable by grinding a tobacco material, such as tobacco leaf. The means by which the tobacco material may be ground is not limited and a person of skill in the art of the present disclosure will be able to select suitable apparatus and / or methods for grinding a tobacco material such as tobacco leaf as part of their common general knowledge. In some examples, the tobacco particles are obtained or obtainable by mill grinding a tobacco material. For instance, using a cutting mill, examples of which are commercially available and known to a person of skill in the art. For instance, a FRITSCH PULVERISETTE 19 cutting mill. In some examples, tobacco particles are obtained or obtainable by grinding, such as mill grinding, a tobacco material and sieving the ground tobacco material, e.g. to obtain a particle size such as those disclosed herein. In some examples the sieving may be integrated into the grinding process, e.g. the grinding apparatus such as a cutting mill may comprise a sieve.[000133] In some examples, the tobacco material from which the tobacco particles are obtained may have been processed. In some examples, the tobacco particles may be obtained or obtainable from a tobacco material that has been extracted with at least one solvent. For example, a waste or by-product of an extraction process such as disclosed in further detail herein. In advantageous examples, the tobacco material may have been ground, e.g. to formsolid tobacco particles, prior to the extraction process such that the solid tobacco particles may be used directly after the extraction process in the composition of the present disclosure.Other Compounds[000134] The composition of the present disclosure may include one or more other compounds as defined below. These compounds are understood to be in addition to the compounds previously defined herein.[000135] In some examples, the composition includes at least one C6 to C18 substituted pyrazine. In some examples the C6 to C18 substituted pyrazine comprises substituents selected from alkyl groups, alkenyl groups, aryl groups, hydroxyl groups, carboxyl groups, alkoxy groups, sulfhydryl groups, thionyl groups, sulfide groups, and combinations thereof. The alkyl groups are preferably C1 to C6 alkyl groups; the alkenyl groups are preferably C2 to C6 alkenyl groups; and the carboxyl groups are preferably ketones or aldehydes such as C2 to C6 ketones. The at least one C6 to C18 substituted pyrazine may be selected from pyrazine, trimethyl- (e.g. 2,3,5-trimethylpyrazine); pyrazine, 2,6-diethyl; pyrazine, tetramethyl- (e.g.2, 3, 5, 6-tetram ethyl pyrazine); 2-methylpyrazine; 2,3-dimethylpyrazine; 2,5-dimethyl pyrazine; 2-ethylpyrazine; isopropenylpyrazine; acetylpyrazine; 2-ethyl-6-methylpyrazine; 2-methoxy-3-methylpyrazine; 2,3-diethylpyrazine, 2-methyl-3-methylsulfanylpyrazine; 1-pyrazin-2-ylethanone; cyclohexylmethylpyrazine; deoxyfructosazine; and combinations thereof.[000136] In some examples, the composition includes a terpene alcohol which may be selected from geranyl linalool, isophytol, dihydrolinalool, phytol, sclareol, 2-[5-methyl-5-vinyltetrahydro-2-furanyl]-2-propanol, a b 2,7,11 Cembratrienodiol 4,6 diol, labdenediol, nerolidol, and combinations thereof.[000137] In some examples, the composition comprises at least one C7 to C18 aromatic acetal which may be present as a tobacco flavour marker, optionally selected from veratraldehyde propylene glycol acetal, 2-phenyl,1,3-dioxan-5-ol, 4-methyl-2-phenyl-1,3-dioxolane, 2-(4-methoxyphenyl)-4-methyl-1,3-dioxolane, and combinations thereof.[000138] In some examples, the composition comprises at least one C3 to C24 carboxylic acid which is optionally selected from benzoic acid, phenylacetic acid, and anhydrides thereof, or C5 to C24 fatty acids.[000139] In some examples, the composition comprises one or more C3 to C24 aliphatic esters which are optionally fatty acid esters selected from: ethyl butyrate, methyl butyrate, methyl hexanoate, ethyl hexanoate, methyl octanoate, ethyl octanoate, methyl decanoate, ethyl decanoate, methyl laurate, ethyl laurate, methyl tetradecanote, ethyl tetradecanoate,methyl palmitate, ethyl pentadecanoate, ethyl palmitate, methyl linoleate, ethyl linolenate, ethyl linoleate, methyl stearate, ethyl stearate, methyl linolenate, docosahexanoic acid methyl ester, methyl pyruvate, ethyl pyruvate, and combinations thereof.[000140] In some examples, the composition comprises at least one C4 to C18 lactone which is optionally selected from valerolactone, undecan-4-olide, dihydroactinidiolide, delta-Decalactone, sclareolide, butyrolactone, but-2-en-4-olide, caprolactone, dl-pantolactone, gamma-octanoic lactone, gamma-nonalactone, alpha-levantanolide, 6-pentyloxan-2-one, gamma-decanolactone, (2,6,6-trimethyl-2-hydroxycyclohexylidene)acetic acid lactone, dodecalactone, loliolide, 5-methoxypsoralen, 6-methoxyfuro[2,3-h]chromen-2-one, 3,4-dihydroisocoumarin, maltol (3-Hydroxy-2-methyl-4H-pyran-4-one), 2, 3-d i hydro-3, 5-dihydroxy-6-methyl-4(h)-pyran-4-one, ethyl maltol (2-Ethyl-3-hydroxy-4H-pyran-4-one), coumarin, 3,4-dihydrocoumarin, 6-methylcoumarin, 6-hydroxy-4-methylcoumarin, 7-hydroxycoumarin, 7-ethoxycoumarin, scopoletin, esculetin, 3-amino-4,7-dihydroxycoumarin, 6-Ethyl-5,6-dihydro-2H-pyran-2-one, pantolactone,, and combinations thereof.[000141] In some examples, the composition may further comprise a bipyridine compound, optionally which is 2,3’-dipyridyl or 4,4'-Methylenedipyridine. In some examples, the composition may be substantially free from bipyridine compounds.[000142] In some examples the composition may comprise at least one norisoprenoid. In some examples the at least one norisoprenoid is selected from damascenone, damascene, ionone, megastigmatrienone, n-methylionone, solanone, 3-hydroxy-beta-damascone, 3-buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl), or a combination thereof.[000143] In some examples, the composition may comprise nicotine.[000144] In some examples, the composition further comprises at least one norisoprenoid and nicotine, optionally wherein the weight ratio of norisoprenoid to nicotine is about 1:10 to 1:1.[000145] In some examples, the composition may comprise at least one aromatic alcohol which is optionally a C7 to C18 aromatic monoalcohol, optionally selected from benzyl alcohol, phenylethanol, phenylmethylcarbinol, 1-phenylpropane-1,2-diol, 1-phenyl-2-butanol, and combinations thereof.[000146] In some examples, the composition further comprises one or more carboxylate esters. In some examples, the carboxylate ester is selected from: ethyl acetate; isopropyl formate; methyl methoxyacetate; methyl 2-m ethyl butyrate; propanoic acid, 2-hydroxy-, ethyl ester; ethyl isovalerate; mono-ethyl succinate; isoamyl isovalerate; 2-methylpentanoyl 2-methylpentanoate; triethyl citrate; 1,2,3-propanetriol,1-acetate; 2-hydroxypropylacetate; 1,1-ethanediol, diacetate; dibutyl phthalate; acetic acid, methyl ester; bis(2-ethylhexyl) benzene-1,3-dicarboxylate; methyl phenylacetate; methyl nicotinate; proline, 2-methyl-5-oxo-, methyl ester; methyl pyruvate; ethyl pyruvate; methyl palmitate; ethyl palmitate; and combinations thereof.[000147] In some examples, the composition further comprises at least one sesquiterpene which optionally may be selected from calamenene, alpha-muurolene, r-cadinene, viridiflorene, longifolene, nootkatone, beta-bisabolol, cedrol, nerolidol, santalol, beta-bisabolene, beta-cedrene, beta-humulene, alpha-cyperone, cyperotundone, 3,7-dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dienone, solavetivone, alantolactone, neophytadiene, guai-1(5)-en-11-ol:acetate, and combinations thereof.[000148] In some examples, the composition further comprises one or more furan derivatives which are optionally selected from furfuryl alcohol, furfural, 5-methyl furfural, ethanone, 1-(2-furanyl)-, 2-pentylfuran, 2-(propan-2-ylsulfanylmethyl)furan, 1-(furan-2-yl)pentan-1-one, furfuryl methyl ether, 2-acetylfuran, 2-acetyl-5-methylfuran, linalooloxide, 2-ethenyl-furan, 5-hydroxymethylfurfural, or a combination thereof.Substance Delivery System[000149] In another aspect of the present disclosure, there is provided a substance delivery system comprising the composition, consumable or container or package described herein. As used herein, the term “delivery system” is intended to encompass systems that deliver at least one substance to a user.[000150] The substance delivery system may be a a non-combustible aerosol provision system, or an aerosol-free delivery system. The substance delivery system is preferably a noncombustible aerosol provision system.[000151] A non-combustible aerosol provision system is a system that releases compounds from an aerosol-generating material without combusting the aerosol-generating material, such as electronic cigarettes, tobacco heating products, and hybrid systems to generate aerosol using a combination of aerosol-generating materials. An aerosol-free delivery system is a system that delivers the at least one substance to a user orally, nasally, Transdermally or in another way without forming an aerosol, including, but not limited to, lozenges, gums, patches, articles comprising inhalable powders, and oral products such as oral tobacco which includes snus or moist snuff, wherein the at least one substance may or may not comprise nicotine.[000152] According to the present disclosure, a “non-combustible” aerosol provision system is one where a constituent aerosol-generating material of the aerosol provision system (orcomponent thereof) is not combusted or burned in order to facilitate delivery of at least one substance to a user. The aerosol provision system may also be referenced herein as an aerosol delivery system. In some examples, the delivery system is a non-combustible aerosol provision system, such as a powered non-combustible aerosol provision system. In some examples, the non-combustible aerosol provision system is an electronic cigarette, also known as a vaping device or electronic nicotine delivery system (END), although it is noted that the presence of nicotine in the aerosol-generating material is not a requirement.[000153] In some examples, the non-combustible aerosol provision system is an aerosolgenerating material heating system, also known as a heat-not-burn system. An example of such a system is a tobacco heating system.[000154] In some examples, the non-combustible aerosol provision system is a hybrid system to generate aerosol using a combination of aerosol-generating materials, one or a plurality of which may be heated. Each of the aerosol-generating materials may be, for example, in the form of a solid, liquid or gel and may or may not contain nicotine. In some examples, the hybrid system comprises a liquid or gel aerosol-generating material and a solid aerosol-generating material. The solid aerosol-generating material may comprise, for example, tobacco or a nontobacco product. Typically, the non-combustible aerosol provision system may comprise a non-combustible aerosol provision device and an article for use with or as the non-combustible aerosol provision device, which is also referred to as a consumable for use with the non-combustible aerosol provision device. The consumable being as defined herein. In some examples, the disclosure relates to consumables comprising aerosol-generating material and configured to be used with non-combustible aerosol provision devices. These consumables are sometimes referred to as articles throughout the disclosure.[000155] In some examples, the non-combustible aerosol provision system, such as a non-combustible aerosol provision device thereof, may comprise a power source and a controller. The power source may, for example, be an electric power source or an exothermic power source. In some examples, the exothermic power source comprises a carbon substrate which may be energised so as to distribute power in the form of heat to an aerosol-generating material or to a heat transfer material in proximity to the exothermic power source.[000156] In some examples, the non-combustible aerosol provision system may comprise an area for receiving the consumable, an aerosol generator, an aerosol generation area, a housing, a mouthpiece, a filter and / or an aerosol-modifying agent. In some examples, the consumable for use with the non-combustible aerosol provision device may comprise aerosolgenerating material, an aerosol-generating material storage area, an aerosol-generatingmaterial transfer component, an aerosol generator, an aerosol generation area, a housing, a wrapper, a filter, a mouthpiece, and / or an aerosol-modifying agent.[000157] In some examples, there is provided a substance delivery system that is an aerosol-free delivery system as defined above.[000158] In some examples, the substance to be delivered may be an aerosol-generating material or a material that is not intended to be aerosolised. As appropriate, either material may comprise, in addition to the composition of the present disclosure, one or more active constituents, one or more flavours, one or more aerosol-former materials and / or one or more functional materials. More information is set out herein.Consumable, Aerosolisable Formulation and Aerosol Generating System[000159] In some examples there is provided a consumable comprising the composition as defined herein, a substrate material, optionally wherein the substrate material comprises a carrier material, a porous material, or a combination thereof. A consumable is an article part or all of which is intended to be consumed during use by a user. In some examples the consumable comprises aerosol-generating material as the substrate material and is therefore an aerosolisable formulation or aerosol-generating system. In some examples, the consumable is a material that is not intended to be aerosolised.[000160] The terms aerosolisable formulation, aerosolisable material, and aerosol-generating material, are used interchangeably herein. Hence, there is provided an aerosolisable formulation comprising the composition as defined herein, an aerosol-former material and optionally nicotine. In some examples the formulation comprises the composition as defined herein, an aerosol-former material and nicotine.[000161] In some examples the formulation comprises the composition in an amount of at least about 1% by weight, such as at least about 5 wt% by weight, preferably at least about 10 wt% by weight. The composition may be present in the formulation in an amount of no greater than about 25% by weight, such as no greater than about 20% by weight, preferably no greater than about 15 wt% by weight. In some examples the composition may be present in the formulation in an amount of from about 1% by weight to about 25% by weight, such as from about 5 wt% by weight to about 20% by weight, preferably from about 10% by weight to about 15% by weight.[000162] The aerosolisable formulation may take various forms, provided that the formulation is capable of generating aerosol, for example when heated, irradiated or energized in any other way, including a semi-solid (such as a gel), a liquid or a solid, which may or may not containan active substance and / or flavourants as defined herein. The aerosol-generating material may comprise one or more active substances and / or flavours, one or more aerosol-former materials, and optionally one or more other functional material.[000163] In some examples, the aerosolisable formulation is a liquid. In some examples the formulation is a liquid and comprises about 1% to about 25% by weight of the composition, about 50 to about 99% by weight of the aerosol-former material, and optionally nicotine, such as about 5 wt% by weight to about 20% by weight of the composition, about 60% to about 98% by weight of the aerosol-former material, and optionally nicotine, preferably about 10% by weight to about 15% by weight of the composition, about 70% to about 95% by weight of the aerosol-former material, and optionally nicotine.[000164] Nicotine may be provided in any suitable amount depending on the desired dosage when the formulation is aerosolised and inhaled by the user. Nicotine may be included in the formulation even if it is already present in the composition. In some examples nicotine is present in an amount of no greater than about 6 wt% based on the total weight of the formulation. In some examples nicotine is present in an amount of from about 0.1 to about 6 wt% based on the total weight of the formulation, such as from about 0.5 to about 6 wt% based on the total weight of the formulation, preferably about 0.5 to about 5 wt% based on the total weight of the formulation.[000165] In some examples the aerosolisable formulation is a liquid and may comprise about 1% to about 25% by weight of the composition, where the composition is defined according to the examples above, about 50 to about 99 wt% of the aerosol-former material, and about 0.1 to about 6 wt% of nicotine.[000166] In some examples the formulation may contain one or more acids in addition to nicotine (as the active agent). In some examples, the one or more acids may be one or more organic acids. In some examples, the one or more acids may be one or more organic acids selected from the group consisting of benzoic acid, levulinic acid, malic acid, maleic acid, fumaric acid, citric acid, lactic acid, acetic acid, succinic acid, and mixtures thereof. When included in the formulation in combination with nicotine, the one or more acids may provide a formulation in which the nicotine is at least partially in protonated (such as monoprotonated and / or diprotonated) form.[000167] In some examples, the one or more organic acids are selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid and combinations thereof.[000168] In some examples, the one or more organic acids consist of levulinic acid and one more organic acids selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, 2-methylbutyric acid, isobutyric acid, acetic acid and combinations thereof.[000169] In some examples, the one or more organic acids are selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid, acetic acid, heptanoic acid, 2-methyl valeric acid, lactic acid, butyric acid and combinations thereof.[000170] In some examples, the one or more organic acids consist of levulinic acid and one more organic acids selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, 2-methylbutyric acid, isobutyric acid, acetic acid, heptanoic acid, 2-methyl valeric acid, lactic acid, butyric acid and combinations thereof.[000171] In some examples, the one or more organic acids consist of benzoic acid and one more organic acids selected from the group consisting of isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, 2-methylbutyric acid, isobutyric acid, acetic acid, heptanoic acid, 2-methyl valeric acid, lactic acid, butyric acid, levulinic acid and combinations thereof.[000172] In some examples, the aerosolisable formulation / aerosol-generating material may be an extruded material or in the form of strands or strips. In some examples there is provided an aerosol generating material / system comprising the composition as defined herein, an aerosol former material, one or more binders, and optionally a botanical material. Optionally a filler may also be present. Optionally, a solvent, such as water, is also present and one or more other components of the aerosol-generating material may or may not be soluble in the solvent.[000173] The aerosol-generating material may comprise or be in the form of an aerosolgenerating film. The aerosol-generating film may comprise a binder, such as a gelling agent, and an aerosol former. Optionally, a substance to be delivered and / or filler may also be present. The aerosol-generating film may have a thickness of about 0.015 mm to about 1 mm. For example, the thickness may be in the range of about 0.05 mm, 0.1 mm or 0.15 mm to about 0.5 mm or 0.3 mm. The aerosol-generating film may be continuous. For example, the film may comprise or be a continuous sheet of material. The sheet may be in the form of a wrapper, it may be gathered to form a gathered sheet or it may be shredded to form a shredded sheet. The shredded sheet may comprise one or more strands or strips of aerosol-generating material.[000174] The aerosol-generating film may be discontinuous. For example, the aerosolgenerating film may comprise one or more discrete portions or regions of aerosol-generating material, such as dots, stripes or lines, which may be supported on a support. In such examples, the support may be planar or non-planar.[000175] The aerosol-generating film may be formed by combining a binder, such as a gelling agent, with a solvent, such as water, an aerosol-former and one or more other components, such as one or more substances to be delivered, to form a slurry and then heating the slurry to volatilise at least some of the solvent to form the aerosol-generating film. The slurry may be heated to remove at least about 60 wt%, 70 wt%, 80 wt%, 85 wt% or 90 wt% of the solvent.[000176] The aerosol-generating material may comprise or be an “amorphous solid”. In some examples, the aerosol-generating materiel comprises an aerosol-generating film that is an amorphous solid. The amorphous solid may be a “monolithic solid”. The amorphous solid may be substantially non-fibrous. In some examples, the amorphous solid may be a dried gel. The amorphous solid is a solid material that may retain some fluid, such as liquid, within it. In some examples, the amorphous solid may, for example, comprise from about 50wt%, 60wt% or 70wt% of amorphous solid, to about 90wt%, 95wt% or 100wt% of amorphous solid.[000177] In some examples, the binder consists of one or more gelling agent(s). Suitably, the aerosolisable formulation or aerosol generating system comprises from about 2 wt% to about 80 wt% binder(s), for example from about 5 wt%, 7 wt%, 10 wt%, 15 wt%, 17 wt%, 20 wt%, or 25 wt% to about 70 wt%, 60 wt%, 50 wt%, 45 wt%, 40 wt%, 35 wt% or 30 wt% of one or more binders (all calculated on a dry weight basis). For example, the aerosolisable formulation or aerosol generating system may comprise about 5-70 wt%, 7-60 wt%, 10-50 wt%, 15-45 wt%, 17-40 wt%, 20-35 wt% or 25-30 wt% of the binder(s).[000178] In some examples, the one or more binders comprises one or more gelling agent(s). In some examples, the one or more binders consist of one or more gelling agent(s). In some examples, the gelling agent comprises a hydrocolloid.[000179] In some examples, the one or more binders comprises (or is) one or more compounds selected from polysaccharide gelling agents, such as alginate, pectin, starch or a derivative thereof, cellulose or a derivative thereof, pullulan, carrageenan, agar and agarose; gelatin; gums, such as xanthan gum, guar gum and acacia gum; silica or silicone compounds, such as PDMS and sodium silicate; clays, such as kaolin; and polyvinyl alcohol.[000180] In some examples the one or more binders comprises (or is) one or more polysaccharide gelling agents. In some examples, the polysaccharide gelling agent is selectedfrom alginate, pectin, starch or a derivative thereof, or cellulose or a derivative thereof. In some examples the polysaccharide gelling agent is selected from alginate and a cellulose derivative.[000181] In some examples, the one or more binders is a polysaccharide gelling agent, optionally wherein the polysaccharide gelling agent is selected from alginate and a cellulose derivative. In some examples, the polysaccharide gelling agent is alginate. In some examples, the alginate is sodium alginate.[000182] In some examples, the polysaccharide gelling agent is a cellulose derivative. Without wishing to be bound by theory, it is believed that such gelling agents do not react with calcium ions to form crosslinks. In some examples the binder is not crosslinked. The absence of crosslinks in the gelling agent may facilitate quicker delivery of the composition (and any optional additional active substances and / or flavours) from the aerosolisable formulation or aerosol generating system. Examples of cellulosic binders (also referred to herein as cellulosic gelling agents or cellulose derivatives) include, but are not limited to, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples the cellulose or derivative thereof is selected from hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose (CMC), hydroxypropyl methylcellulose (HPMC), methyl cellulose, ethyl cellulose, cellulose acetate (CA), cellulose acetate butyrate (CAB), and cellulose acetate propionate (CAP). In some examples, the cellulose derivative is CMC. For example, in some examples, the binder comprises (or is) one or more of alginate, pectin, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, pullulan, xanthan gum, guar gum, carrageenan, agarose, acacia gum, fumed silica, PDMS, sodium silicate, kaolin and polyvinyl alcohol.[000183] In some examples, the binder comprises (or is) one or more of hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethylcellulose, guar gum, acacia gum, alginate and / or pectin. In some cases, the binder comprises (or is) alginate and / or pectin, and may be combined with a setting agent (such as a calcium source) during formation of the aerosolisable formulation or aerosol generating system. In some cases, the binder may comprise a calcium-crosslinked alginate and / or a calcium-crosslinked pectin. In some examples, the binder comprises (or is) alginate, optionally wherein the alginate is present in the aerosolisable formulation in an amount of from about 5-70 wt%, 7-60 wt%, 10-50 wt%, or 15-45 wt%, of the aerosolisable formulation or aerosol generating system (calculated on a dry weight basis). In some examples, alginate is the only binder present in the aerosolisable formulation / aerosol generating system. In other examples, the binder comprises alginate and at least one furtherbinder, such as pectin. In particular examples, the binder is carboxymethylcellulose, optionally wherein the carboxymethylcellulose (CMC) is present in an amount of about 2-80 wt%, for example about 5-70 wt%, 10-60 wt%, 15-50 wt%, 17-45 wt%, 20-40 wt% or about 30 wt%. In some examples, CMC is the only binder present in the aerosolisable formulation / aerosol generating system.[000184] The aerosolisable formulation or aerosol generating material may further comprise a filler. Use of a filler may help to reduce tackiness of the aerosolisable formulation / aerosol generating material, for example if high levels of aerosol-former material are present. Suitably, the aerosolisable formulation / aerosol generating material comprises from about 2 wt% to about 60 wt% binder and any optional filler. In some examples, filler is present in an amount of less than about 50 wt% of a filler, such as from about 1 wt% to 50 wt%, or 5 wt% to 40 wt%, or 5 wt% to 30 wt%, or 10 wt% to 20 wt%. In other examples, filler is present in an amount of less than 20 wt%, suitably less than 10 wt% or less than 5 wt%. In some cases, the aerosolisable formulation comprises less than 1 wt% of a filler, and in some cases, comprises no filler. The filler, if present, may comprise one or more inorganic filler materials, such as calcium carbonate, perlite, vermiculite, diatomaceous earth, colloidal silica, magnesium oxide, magnesium sulphate, magnesium carbonate, and suitable inorganic sorbents, such as molecular sieves. The filler may comprise one or more organic filler materials such as wood pulp; tobacco pulp; hemp fibre; starch and starch derivatives, such as maltodextrin; chitosan; and cellulose and cellulose derivatives, such as ground cellulose, microcrystalline cellulose and nanocrystalline cellulose. In particular cases, the aerosolisable formulation comprises no calcium carbonate such as chalk.[000185] In particular examples which include filler, the filler is fibrous. For example, the filler may be a fibrous organic filler material such as wood pulp, tobacco pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous organic filler material may be wood pulp, hemp fibre, cellulose or cellulose derivatives. In some examples, the fibrous filler is wood pulp. Without wishing to be bound by theory, it is believed that including fibrous filler in an aerosolisable formulation may increase the tensile strength of the material. This may be particularly advantageous in examples wherein the aerosolisable formulation or aerosol generating material is provided as a sheet, such as when a sheet circumscribes a rod of aerosolisable or aerosol generating material.[000186] The aerosol-former material may comprise one or more constituents capable of forming an aerosol. In some examples, the aerosol-former material may comprise one or more of glycerol, propylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, 1,3-butylene glycol, erythritol, meso-Erythritol, ethyl vanillate, ethyl laurate, a diethyl suberate,triethyl citrate, triacetin, a diacetin mixture, benzyl benzoate, benzyl phenyl acetate, tributyrin, lauryl acetate, lauric acid, myristic acid, and propylene carbonate. In heated products, the aerosol-former material can be present in an amount of greater than 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14% or 15% by weight of the aerosol-generating material.[000187] The consumable may comprise one or more further constituents. In particular, one or more further constituents may be selected from one or more active agents, and / or one or more functional constituents. In some examples, it may be desirable for the composition to comprise only some of the components disclosed herein, and this composition combined or used with a known active or flavourant, such as menthol or CBD, in a consumable to create a cigarette-like experience with an added sensation or effect.[000188] The active agent as used herein may be a physiologically active material, which is a material intended to achieve or enhance a physiological response. The active agent may, for example, be selected from nutraceuticals, nootropics, psychoactives. The active substance may be naturally occurring or synthetically obtained. The active agent may comprise for example nicotine, caffeine, taurine, theine, vitamins such as B6 or B12 or C, melatonin, cannabinoids, or constituents, derivatives, or combinations thereof. The active substance may comprise one or more constituents, derivatives or extracts of tobacco, cannabis or another botanical. In some examples, the active substance is a legally permissible recreational drug. In some examples, the active agent comprises nicotine. In some examples, the active agent comprises caffeine, melatonin, or vitamin B12.[000189] In some examples, the active agent may comprise one or more constituents, derivatives or extracts of cannabis, such as one or more cannabinoids or terpenes. Cannabinoids are a class of natural or synthetic chemical compounds that act on cannabinoid receptors (i.e., CB1 and CB2) in cells that repress neurotransmitter release in the brain. Cannabinoids are cyclic molecules exhibiting particular properties such as the ability to cross the blood-brain barrier with ease. Cannabinoids may be naturally occurring (phytocannabinoids) from plants such as cannabis, (endocannabinoids) from animals, or artificially manufactured (synthetic cannabinoids). Cannabis species express at least 85 different phytocannabinoids, and these may be divided into subclasses, including cannabigerols, cannabichromenes, cannabidiols, tetrahydrocannabinols, cannabinols and cannabinodiols, and other cannabinoids.[000190] In some examples, the at least one cannabinoid may be selected from cannabigerol (CBG), cannabigerolic acid (CBGA), cannabichromene (CBC), cannabichromenic acid (CBCA), cannabidiol (CBD), cannabidolic acid (CBDA), tetrahydrocannabinol (THC), including its isomers Δ6a,10a-tetrahydrocannabinol (Δ6a,10a-THC), Δ6a(7)-tetrahydrocannabinol(Δ6a(7)-THC), Δ8-tetrahydrocannabinol (Δ8-THC), Δ9-tetrahydrocannabinol (Δ9-THC), Δ10-tetrahydrocannabinol (Δ10-THC), Δ9,11-tetrahydrocannabinol (Δ9,11-THC), tetrahydrocannabinolic acid (THCA), cannabinol (CBN), cannabinolic acid (CBNA), and cannabinodiol (CBDL), cannabicyclol (CBL), cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabigerol monomethyl ether (CBGM) and combinations thereof. According to one example, the at least one cannabinoid may be selected from cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), tetrahydrocannabinol (THC), cannabinol (CBN) and combinations thereof.[000191] Naturally derived cannabinoids are generally present in their carboxylated form. In this regard, cannabidiol (CBD) and cannabidolic acid (CBDA) are the respective decarboxylated and carboxylated forms.[000192] The cannabinoid referred to herein may be present in either the carboxylated or decarboxylated form. Exemplary carboxylated cannabinoid in this regard include cannabigerolic acid (CBGA), cannabichromenic acid (CBCA), cannabinolic acid (CBNA), tetrahydrocannabinolic acid (THCA), cannabidolic acid (CBDA) and combinations thereof.[000193] As noted herein, the active substance may comprise or be derived from one or more botanicals or constituents, derivatives or extracts thereof. As used herein, the term “botanical” includes any material derived from plants including, but not limited to, extracts, leaves, bark, fibres, stems, roots, seeds, flowers, fruits, pollen, husk, shells or the like. Alternatively, the material may comprise an active compound naturally existing in a botanical, obtained synthetically. The material may be in the form of liquid, gas, solid, powder, dust, crushed particles, an extrudate, granules, pellets, shreds, strips, sheets, or the like. Example botanicals are tobacco, eucalyptus, star anise, hemp, cocoa, cannabis, fennel, lemongrass, peppermint, spearmint, rooibos (Aspalathus linearis), chamomile, flax, ginger, ginkgo biloba, hazel, hibiscus, laurel, licorice (liquorice), matcha, mate, orange skin, papaya, rose, sage, tea such as green tea or black tea, thyme, clove, cinnamon, coffee, aniseed (anise), basil, bay leaves, cardamom, coriander, cumin, nutmeg, oregano, paprika, rosemary, saffron, lavender, lemon peel, mint, juniper, elderflower, vanilla, Wintergreen, beefsteak plant, curcuma, turmeric, sandalwood, cilantro, bergamot, orange blossom, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, geranium, mulberry, ginseng, theanine, theacrine, maca, ashwagandha, damiana, guarana, chlorophyll, baobab or any combination thereof. The mint may be chosen from the following mint varieties: Mentha Arventis, Mentha c.v., Mentha niliaca, Mentha piperita, Mentha piperita citratac.v., Mentha piperita c.v, Mentha spicata crispa, Mentha cardifolia, Memtha longifolia, Mentha suaveolens variegata, Mentha pulegium, Mentha spicata c.v. and Mentha suaveolens.[000194] In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is tobacco. In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from eucalyptus, star anise, cocoa and hemp. In some examples, the active agent comprises or is derived from one or more botanicals or constituents, derivatives or extracts thereof and the botanical is selected from rooibos and fennel. In some examples, the consumable may include a botanical material in addition to any plant material, e.g. tobacco extract, present in the composition. In some examples, this may be advantageous to include other flavourants and / or aroma compounds and / or active agents in the second plant material.[000195] When nicotine is present in the formulation, it may be present in protonated and / or un-protonated form. In some examples, the formulation comprises nicotine in unprotonated form and nicotine in monoprotonated form. It may also be that small amounts of diprotonated nicotine are present. In one aspect the formulation comprises nicotine in unprotonated form, nicotine in monoprotonated form and nicotine in diprotonated form. As will be understood by one skilled in the art, the protonated form of nicotine may be prepared by reacting unprotonated nicotine with an acid. The acid(s) are one or more suitable acids, such as organic acids. In some examples, the acid is a carboxylic acid. The carboxylic acid may be any suitable carboxylic acid. In some examples, the acid is a mono-carboxylic acid. In some examples, the acid is selected from the group consisting of acetic acid, benzoic acid, levulinic acid, lactic acid, formic acid, citric acid, pyruvic acid, succinic acid, tartaric acid, oleic acid, sorbic acid, propionic acid, phenylacetic acid, and mixtures thereof. In some examples, the acid is benzoic acid and / or levulinic acid. In some examples, the acid is benzoic acid. In alternative examples, the aerosolisable formulation may be free of inorganic acids and their corresponding salts. For example, the aerosolisable formulation may be free of phosphoric acids.[000196] Where present, the amount of organic acid present may vary. The formulation may comprise from about 0.01% to about 10% by weight of organic acid, present as one or more organic acids, based on the total weight of the formulation. In some examples, the formulation comprises at least about 0.01%, at least about 0.1 %, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or at least about 10% organic acid by weight, based on the total weight of the formulation. In some preferred examples, the formulation comprises from about 0.01% to about 5% by weight of organic acid.For example, the formulation comprises an organic acid in an amount of from about 0.1% to about 2.5% by weight of the formulation. In the case where a salt of an organic acid is added (e.g., citric acid anhydrate), the percent by weight is calculated based on the weight of the free acid, not including any counter-ion which may be present.[000197] In some examples, the further constituent comprises a flavour. As used herein, the terms "flavour" and "flavourant" refer to materials which, where local regulations permit, may be used to create a desired taste, aroma, or other somatosensorial sensation in a product for adult consumers. They may include naturally occurring flavour materials, botanicals, extracts of botanicals, synthetically obtained materials, or combinations thereof (e.g., tobacco, cannabis, licorice (liquorice), hydrangea, eugenol, Japanese white bark magnolia leaf, chamomile, fenugreek, clove, maple, matcha, menthol, Japanese mint, aniseed (anise), cinnamon, turmeric, Indian spices, Asian spices, herb, Wintergreen, cherry, berry, red berry, cranberry, peach, apple, orange, mango, clementine, lemon, lime, tropical fruit, papaya, rhubarb, grape, durian, dragon fruit, cucumber, blueberry, mulberry, citrus fruits, Drambuie, bourbon, scotch, whiskey, gin, tequila, rum, spearmint, peppermint, lavender, aloe vera, cardamom, celery, cascarilla, nutmeg, sandalwood, bergamot, geranium, khat, naswar, betel, shisha, pine, honey essence, rose oil, vanilla, lemon oil, orange oil, orange blossom, cherry blossom, cassia, caraway, cognac, jasmine, ylang-ylang, sage, fennel, wasabi, piment, ginger, coriander, coffee, hemp, a mint oil from any species of the genus Mentha, eucalyptus, star anise, cocoa, lemongrass, rooibos (Aspalathus linearis), flax, ginkgo biloba, hazel, hibiscus, laurel, mate, orange skin, rose, tea such as green tea or black tea, thyme, juniper, elderflower, basil, bay leaves, cumin, oregano, paprika, rosemary, saffron, lemon peel, mint, beefsteak plant, curcuma, cilantro, myrtle, cassis, valerian, pimento, mace, damien, marjoram, olive, lemon balm, lemon basil, chive, carvi, verbena, tarragon, limonene, thymol, camphene), flavour enhancers, bitterness receptor site blockers, sensorial receptor site activators or stimulators, sugars and / or sugar substitutes (e.g., sucralose, acesulfame potassium, aspartame, saccharine, cyclamates, lactose, sucrose, glucose, fructose, sorbitol, or mannitol), and other additives such as charcoal, chlorophyll, minerals, botanicals, or breath freshening agents. They may be imitation, synthetic or natural ingredients or blends thereof. They may be in any suitable form, for example, liquid such as an oil, solid such as a powder, or gas.[000198] The flavour may be added to the consumable as part of a so-called “flavour block”, where one or more flavours are blended together and then added to the substrate material.[000199] In some examples, the flavour comprises menthol, spearmint and / or peppermint. In some examples, the flavour comprises flavour components of cucumber, blueberry, citrus fruits and / or redberry. In some examples, the flavour comprises eugenol. In some examples, theflavour comprises flavour components extracted from tobacco. In some examples, the flavour comprises flavour components extracted from cannabis.[000200] In some examples, the flavour may comprise a sensate, which is intended to achieve a somatosensorial sensation which are usually chemically induced and perceived by the stimulation of the fifth cranial nerve (trigeminal nerve), in addition to or in place of aroma or taste nerves, and these may include agents providing heating, cooling, tingling, numbing effect. A suitable heat effect agent may be, but is not limited to, vanillyl ethyl ether and a suitable cooling agent may be, but not limited to eucalyptol (if not already present in the composition), WS-3.[000201] Where present, a flavouring agent may be included in the formulation in an amount up to about 10% by weight, such as up to about 5% by weight, such as up to about 1% by weight of the formulation. In some examples, a flavouring agent is present in an amount of from about 0.01 % to about 5% by weight, preferably in an amount of from about 0.1 % to about 2.5% by weight of the formulation, and more preferably in an amount of from about 0.25% to about 1% by weight of the formulation.[000202] The one or more other functional constituents may comprise one or more of colouring agents, pH regulators, preservatives, stabilizers, and / or antioxidants. A colouring agent may be employed in amounts sufficient to provide the desired physical attributes to the product. The colouring agent may, for example, alter the visual appearance of the formulation and further, may colour-match the formulation to other components of the aerosolisable formulation or other components of a consumable comprising the formulation. In some examples, the colouring agent may be included so as to confer the aerosolisable formulation with a brown appearance.[000203] When the consumable comprises aerosol-generating material, the consumable may further comprise one or more other components, such as an aerosol-generating section, an aerosol-generating material storage area, an aerosol-generating material transfer component, an aerosol generation area, a housing, a wrapper, a mouthpiece, a filter and / or an aerosolmodifying agent.[000204] A consumable may also comprise an aerosol generator, such as a heater, that emits heat to cause the aerosol-generating material to generate aerosol in use. The heater may, for example, comprise combustible material, a material heatable by electrical conduction, or a susceptor. The aerosol-generating section and / or the aerosol-generating material may comprise a cavity for receiving an aerosol-generator, such as a blade or a pin, of a noncombustible aerosol provision device. A susceptor is a material that is heatable by penetrationwith a varying magnetic field, such as an alternating magnetic field. The susceptor may be an electrically-conductive material, so that penetration thereof with a varying magnetic field causes induction heating of the material. The material may be a magnetic material, so that penetration thereof with a varying magnetic field causes magnetic hysteresis heating of the heating material. The susceptor may be both electrically-conductive and magnetic, so that the susceptor is heatable by both mechanisms. A device or a consumable may comprise the susceptor. For example, the aerosol-generating section of a consumable may comprise aerosol-generating material and a susceptor.[000205] A consumable may be in the form of a rod and may comprise a downstream mouthend and an upstream end.[000206] Consumables are often named according to their length: "regular" (typically in the range 68-75 mm, e.g. from about 68 mm to 25 about 72 mm), "short" or "mini" (68 mm or less), "king-size" (typically in the range 75-91 mm, e.g. from about 79 mm to about 88 mm), "long" or "super-king" (typically in the range 91-105 mm, e.g. from about 94 mm to about 101 mm) and "ultra-long" (typically in the range from about 110 mm to about 121 mm). Typical heating product consumable circumferences are: "regular" (about 23-25 mm), "wide" (greater than 25 mm), "slim" (about 22-23 mm), "demi-slim" (about 19-22 mm), "super-slim" (about 16-19 mm), and "micro-slim" (less than about 16 mm). Accordingly, for example, a consumable in demi-slim size will have a length of about 75 mm and a circumference of about 21 mm. A consumable in a king-size, super-slim format will have a length of about 83 mm and a circumference of about 17 mm, for example.[000207] Articles may include an aerosol-generating material and a downstream portion downstream of the aerosol-generating material, and each format may be produced with downstream portions of different lengths. The downstream portion length will usually be from about 30 mm to 50 mm. A tipping paper connects the downstream portion to the aerosol generating material and will usually have a greater length than the downstream portion, for example from 3 to 10 mm longer, such that the tipping paper covers the downstream portion and overlaps the aerosol generating material, for instance in the form of a rod, to connect the downstream portion to the rod.[000208] The consumable may comprise aerosol-generating material that is wrapped in a wrapper. The wrapper may, for example, be a paper or a paper-backed foil wrapper. The wrapper can be permeable, partially permeable or impermeable to gas.[000209] An aerosol-modifying agent is a substance, typically located downstream of the aerosol generation area, that is configured to modify the aerosol generated, for example bychanging the taste, flavour, acidity or another characteristic of the aerosol. The aerosolmodifying agent may be provided in an aerosol-modifying agent release component, that is operable to selectively release the aerosol-modifying agent. The aerosol-modifying agent may, for example, be an additive or a sorbent. The aerosol-modifying agent may, for example, comprise one or more of a flavourant, a colourant, water, and a carbon adsorbent. The aerosol-modifying agent may, for example, be a solid, a liquid, or a gel. The aerosol-modifying agent may be in powder, thread or granule form. The aerosol-modifying agent may be free from filtration material.[000210] An aerosol generator is an apparatus configured to cause aerosol to be generated from the aerosol-generating material. In some examples, the aerosol generator is a heater configured to subject the aerosol-generating material to heat energy, so as to release one or more volatiles from the aerosol-generating material to form an aerosol. In some examples, the aerosol generator is configured to cause an aerosol to be generated from the aerosolgenerating material without heating. For example, the aerosol generator may be configured to subject the aerosol-generating material to one or more of vibration, increased pressure, or electrostatic energy. The aerosol generator may comprise a projection that is configured to subject the aerosol-generating material to heat energy, such as a blade or pin heater. The projection may be configured for insertion into the aerosol-generating section of a consumable. The aerosol generator may be configured to heat the aerosol-generating material to a temperature of up to about 500 °C, about 450 °C, or about 400 ° C or about 350 °C.[000211] Exemplary aerosol generator technologies include: for heater technologies: a resistive heater, an infrared heater, an induction heater, a laser heater, a plasma heater, a microfluidic heater, a convection heater, allotrope of carbon heater, carbon foam heater, a radio-frequency heater, an electro-resistive heater, a halogen heater; for non-heating technology: vibration vaporiser, surface acoustic wave vaporiser, increased pressure vaporiser, electrostatic energy vaporiser, an ultrasonic vaporiser.Containers and Packages[000212] In a further aspect there is provided a container or package comprising the composition or consumable as defined herein. In some examples, there is provided a pouched oral product comprising a saliva permeable pouch. In other examples, there is provided a cartridge for an aerosol provision system.[000213] The pouched oral product is configured for oral use which means that the composition is provided in a form such that during use, saliva in the mouth of the user causes one or more of the components of the composition (e.g., flavoring agents and / or activeingredients) to pass into the mouth of the user. In some examples, the composition is adapted to deliver components to a user through mucous membranes in the user's mouth, the user's digestive system, or both, and, in some instances, said component is an active ingredient (including, but not limited to, for example, nicotine, a stimulant, vitamin, an amino acid, a botanical, or combinations thereof) that can be absorbed through the mucous membranes in the mouth or absorbed through the digestive tract when the product is used.[000214] The pouched oral product may comprise a particulate filler component. As used herein, the term "particulate" refers to a material in the form of a plurality of individual particles. Particulate fillers may fulfill multiple functions, such as enhancing certain organoleptic properties such as texture and mouthfeel, enhancing cohesiveness or compressibility of the product, and the like. Generally, the filler is a porous particulate material and often is cellulose-based. For example, suitable fillers are any non-tobacco plant material or derivative thereof, including cellulose materials derived from such sources. Examples of cellulosic non-tobacco plant material include cereal grains (e.g., maize, oat, barley, rye, buckwheat, and the like), sugar beet (e.g., FIBREX® brand filler available from International Fiber Corporation), bran fiber, and mixtures thereof. Non-limiting examples of derivatives of non-tobacco plant material include starches (e.g., from potato, wheat, rice, corn), natural cellulose, and modified cellulosic materials. Additional examples of potential fillers include maltodextrin, dextrose, calcium carbonate, calcium phosphate, lactose, mannitol, xylitol, and sorbitol. Combinations of fillers can also be used.[000215] In some examples, the particulate filler comprises a starch, a cellulose material, or both. " Starch" as used herein may refer to pure starch from any source, modified starch, or starch derivatives. Starch is present, typically in granular form, in almost all green plants and in various types of plant tissues and organs (e.g., seeds, leaves, rhizomes, roots, tubers, shoots, fruits, grains, and stems). Starch can vary in composition, as well as in granular shape and size. Often, starch from different sources has different chemical and physical characteristics. A specific starch can be selected for inclusion in the mixture based on the ability of the starch material to impart a specific organoleptic property to composition. Starches derived from various sources can be used. For example, major sources of starch include cereal grains (e.g., rice, wheat, and maize) and root vegetables (e.g., potatoes and cassava). Other examples of sources of starch include acorns, arrowroot, arracacha, bananas, barley, beans (e.g., favas, lentils, mung beans, peas, chickpeas), breadfruit, buckwheat, canna, chestnuts, colacasia, katakuri, kudzu, malanga, millet, oats, oca, Polynesian arrowroot, sago, sorghum, sweetpotato, quinoa, rye, tapioca, taro, tobacco, water chestnuts, and yams. Certain starches are modified starches. A modified starch has undergone one or more structural modifications, often designed to alter its high heat properties. Some starches have beendeveloped by genetic modifications and are considered to be "modified" starches. Other starches are obtained and subsequently modified. For example, modified starches can be starches that have been subjected to chemical reactions, such as esterification, etherification, oxidation, depolymerization (thinning) by acid catalysis or oxidation in the presence of base, bleaching, transglycosylation and depolymerization (e.g., dextrinization in the presence of a catalyst), cross-linking, enzyme treatment, acetylation, hydroxypropylation, and / or partial hydrolysis. Other starches are modified by heat treatments, such as pregelatinization, dextrinization, and / or cold-water swelling processes. Certain modified starches include monostarch phosphate, distarch glycerol, distarch phosphate esterified with sodium trimetaphosphate, phosphate distarch phosphate, acetylated distarch phosphate, starch acetate esterified with acetic anhydride, starch acetate esterified with vinyl acetate, acetylated distarch adipate, acetylated distarch glycerol, hydroxypropyl starch, hydroxypropyl distarch glycerol, starch sodium octenyl succinate.[000216] In some examples, the particulate filler comprises a cellulose material. One nonlimiting example of a suitable cellulose material for use in the products described herein is microcrystalline cellulose (" MCC"). The MCC may be synthetic or semi-synthetic, or it may be obtained entirely from natural celluloses. The MCC may be selected from the group consisting of AVICEL® grades PH-100, PH-102, PH-103, PH-105, PH-112, PH-113, PH-200, PH-300, PH-302, VIVACEL® grades 101, 102, 12, 20 and EMOCEL® grades 50M and 90M, and the like, and mixtures thereof.[000217] The filler component may further comprise a cellulose derivative or a combination of such derivatives. In some examples, the cellulose derivative is a cellulose ether (including carboxyalkyl ethers), meaning a cellulose polymer with the hydrogen of one or more hydroxyl groups in the cellulose structure replaced with an alkyl, hydroxyalkyl, or aryl group. Nonlimiting examples of such cellulose derivatives include methylcellulose, hydroxypropylcellulose (" HPC"), hydroxypropylmethylcellulose (" HPMC"), hydroxyethyl cellulose, and carboxymethylcellulose (" CMC"). In some examples, the composition comprises from about 0.1% to about 5% of HPC or other cellulose derivative by weight, e.g., about 1% to about 3% HPC or other cellulose derivative by weight, based on the total weight of the composition.[000218] In some examples, a particulate filler can be characterized as substantially spherical, such as cellulose spheres. By “substantially spherical” is meant at least a portion of the particulate filler component is in the shape of a sphere and / or is “sphere-like’ in shape. As such, “substantially spherical” encompasses slightly elongated (e.g., oval) shapes, slightly flattened shapes, and the like. Substantially spherical particulate filler components are intended to be distinguished from conventional particulate filler components (e.g.,commercially available “fillers” or “particulate fillers” that are not explicitly designed as “spherical”). Such conventional particulate filler components typically substantially comprise particles with rather irregular shapes. In some cases, at least some (e.g., including a majority) of such conventional particulate filler components comprise one or more edges (e.g., jagged edges) that are typically not observable on substantially spherical particulate filler components as employed in the context of the present disclosure. Further, the uniformity of the particle shapes and sizes of a substantially spherical filler component is generally much greater than that of a conventional particulate filler component.[000219] In some examples, the substantially spherical filler component comprises MCC. In some examples, the substantially spherical filler component comprises solid (although porous) MCC spheres. In some examples, the substantially spherical filler component comprises hollow MCC spheres. In some examples, the center / core of such hollow MCC spheres may be unfilled; in some examples, the center / core of such hollow MCC spheres may be filled with one or more additional components (e.g., flavorants, fillers, active ingredients, etc.). Examples of suitable MCC spheres include, but are not limited to, Vivapur® MCC spheres from JRS Pharma, available, e.g., with particle sizes of 100-200 pm (Vivapur® 100), 200-355 pm (Vivapur® 200), 355-500 pm (Vivapur® 350), 500-710 pm (Vivapur® 500), 710-1000 pm (Vivapur®700), and 1000-1400 pm (Vivapur® 1000). Further examples of suitable MCC spheres include, but are not limited to, Celphere™ MCC spheres from Asahi Kasei Corporation, available, e.g., with particle sizes of 75-212 pm (Celphere™ SCP-100), 106-212 pm (Celphere™ CP-102), 150-300 pm (Celphere™ CP-203), 300-500 pm (Celphere™ CP-305), and 500-710 pm (Celphere™ CP-507).[000220] The quantity of the particulate filler (e.g., MCC) may vary. The amount of filler component on a wet weight basis can vary but is typically up to about 75 percent of the total product by weight. A typical range of filler component can be from about 10 to about 75 percent, for example, from about 10, about 15, about 20, about 25, or about 30, to about 35, about 40, about 45, about 50, about 55, about 60, about 65, about 70, or about 75 weight percent (e.g., about 15 to about 60 weight percent, or about 25 to about 45 weight percent) on a wet weight basis. In some examples, the amount of particulate filler component is at least about 10 percent by weight, such as at least about 20 percent, or at least about 25 percent, or at least about 30 percent, or at least about 35 percent, or at least about 40 percent, based on the total weight of the product.[000221] The water content of the product, prior to use by a consumer, may vary according to the desired properties. Typically, the oral product is less than about 60 percent by weight of water, and generally is from about 1 to about 60% by weight of water, for example, from about5 to about 55, about 10 to about 50, about 20 to about 45, or about 25 to about 40 percent water by weight, including water amounts of at least about 5% by weight, at least about 10% by weight, at least about 15% by weight, and at least about 20% by weight, based on the total weight of the product.Process and Aerosol / Aerosolised Formulation[000222] In some examples described herein there is provided a process for forming an aerosol, the process comprising providing an aerosolisable formulation as defined herein and aerosolising the formulation. The process may alternatively comprise providing the aerosol generating system as defined herein or the aerosol provision system defined herein and aerosolising the formulation or consumable in the system.[000223] In another aspect, there is provided an aerosolised formulation formed from a noncombustible aerosol provision device, wherein the aerosolised formulation comprises one or more of the compounds defined herein.[000224] In some examples, the aerosolised formulation comprises at least two diterpenoids derivable from a Nicotiana species.[000225] In some examples, the aerosolised formulation comprises at least two diterpenoids selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, a cembrane diterpenoid, and a labdane diterpenoid, wherein the cembrane diterpenoid is selected from the group consisting of cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, sclareol acetate, incensole, and incensole acetate, and / or wherein the labdane diterpenoid is selected from the group consisting of abienol, abienol acetate, labdenediol, and labdenediol acetate.[000226] In some examples, the aerosolised formulation comprises at least two diterpenoids selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol.[000227] In some examples, the aerosolised formulation comprises nicotyrine and at least one component selected from the group consisting of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, or anatabine.[000228] In some examples, the aerosolised formulation is not a combustible tobacco product. As used herein, a “combustible” tobacco product is one where a constituent aerosol-generatingmaterial of the product is combusted or burned during use in order to facilitate delivery of at least one substance to a user. Examples of a combustible tobacco product include a cigarette, a cigarillo, and a cigar.[000229] In some examples, the aerosolised formulation is obtainable by aerosolising the composition as defined herein.[000230] The present invention will now be described with reference to the following nonlimiting examples.ExamplesExample 1[000231] Nine different tobacco extracts were prepared from different blends of air-cured Burley, fire-cured Dark, sun-cured Oriental, and flue-cured Virginia tobacco using a variety of solvent extraction methods. Each of these extracts was then chemically analysed to determine the components present. The analysis was performed using GC-MS. Specifically, compounds could be identified based on GC-MS spectra as compared to reference MS libraries and reference compounds. Tables 1a and 1b below summarise the levels of the components present in the tobacco extracts analysed.Table 1a: Extract analysis - DiterpenoidsTable 1b: Extract analysis - Alkaloids[000232] The above extracts show levels of diterpenoids and alkaloids that are not typically found in synthetically derived consumables typically used in substance delivery systems. Thus, the above components act as a marker for providing an authentic tobacco aroma and so are preferable for enabling delivery of an FMC-like experience.Example 2[000233] Four different tobacco extracts were prepared. The extracts were formed from two different blends of air-cured burley, sun-cured oriental, and flue-cured Virginia tobacco using either the simultaneous distillation extraction (SDE) or supercritical fluid extraction (SFE) methods described below.Simultaneous Distillation-Extraction (SDE)[000234] 300 g of ground tobacco was mixed with 2800 mL of water in a round bottom flask. The resulting solution had a pH of 6 and glass beads were added to prevent bumping. The round bottom flask was fitted with a Clevenger apparatus and the tobacco solution heated to 120 °C. The volatile and semi-volatile compounds were collected in pentane:ethyl ether solution (15 mL, 2:1 v / v) maintained at -8 °C. After 6 h of extraction, the pentane:ethyl ether solution containing volatile and semi-volatile compounds was collected and dried using an open package column containing anhydrous sodium sulfate, filtered throughout Whatman filter paper (No. 2) and concentrated under controlled conditions (magnetic stirring: 200 rpm; water bath 40 °C) to prevent the loss of volatile compounds and exchange the pentane:ethyl ether solvent with ethanol.Supercritical Fluid Extraction (SFE)[000235] 260 g of ground tobacco was placed in a 1 L extraction vessel using supercritical CO₂ (1000 g / h) as solvent. No co-solvent was used throughout the extraction process. The system was pressurised to 100-300 bar (ensuring a profile of volatile and semi-volatile compounds), and heated at a temperature of 60°C. The extracts were collected in twocontainers: one for the volatile fraction and one for the non-volatile fraction. The volatile fraction is collected first, pressure at 100 bar and for a period of 1 hour. The non-volatile fraction is collected second, the pressure being increased to 300 bar and extraction conducted for a period of 1.5 hours. Only the non-volatile fraction is retained. The non-volatile fraction underwent a clean-up step with acetone, with the solvent being completely dried by the end of the process. The extract was collected in a bottle and kept in a refrigerated environment.Analysis[000236] Each of the extracts was then chemically analysed to determine the components present. The extracts were analysed using HTS-FIA-HRMS (High Throughput Screening - Flow Injection Analysis - High Resolution Mass Spectra) on a Synapt-G2Si instrument. The results are set out in Table 2a and 2b below. “X” indicates the presence of a component, indicates the absence of a component.Table 2a: Extract analysis - DiterpenoidsTable 2b: Extract analysis - Alkaloids[000237] As can be seen in the above Tables, extracts are provided comprising diterpenoids and / or alkaloids that are not typically found in synthetically derived consumables used in non-combustible substance delivery systems. The above extracts would therefore be expected to provide a more FMC-like experience when used to provide the flavour of a composition compared to typical synthetically derived consumables.Example 3[000238] A difference between e-liquids obtained from tobacco liquid extracts compared to synthetic tobacco is the presence of naturally occurring acids in the tobacco extract. To understand the chemical and sensorial behaviour of such acids and identify alternatives to acids presently included in synthetic tobacco e-liquids (lactic acid and benzoic acid), a study was performed to determine the binding affinities of acids found naturally in tobacco to their cognate receptor, TRPV1. The reference compounds used in this study were benzoic acid and lactic acid. These molecules were selected as benchmarks to contextualize and compare the binding affinities obtained for the compounds of interest.[000239] The test compounds were: phenylacetic acid, heptanoic acid, 3-methylpentanoic acid, 2-methylvaleric acid, levulinic acid, 2-methylbutyric acid, isovaleric acid, valeric acid, isobutyric acid, butyric acid, and acetic acid.[000240] The affinity values considered throughout the analysis are the binding affinity scores (kcal / mol) obtained from compound-receptor interaction analyses derived from molecular docking simulations. These values represent the predicted strength of interaction between each ligand (test or reference compound) to the simulated molecular receptor.[000241] It will be appreciated by one skilled in the art that each of the compounds may be capable of binding to suitable receptors to act as the required agonist, antagonist or inhibitor. When a potential modulator interacts with a receptor then the interaction will have a given binding energy. The binding energy may be determined based on the follow equation:[000242] More specifically, the modulator and receptor involves several molecular interactions (e.g., van der Waals, electrostatic, hydrogen bonds, hydrophobic, and others) and physical-chemical complementarity among the receptor and the modulator. The protein structure file (receptor) may be retrieved from the Protein Data Bank and was described using electron microscopy model. The details are as follows: TRPV1: PDB: 7LR0, https: / / www.rcsb.org / structure / 7LR0, DOI: 10.2210 / pdb7lr0 / pdb. The receptors hydrogen atoms may be added, according to appropriate hybridization geometry, to those atoms based on built-in modules to add partial charges, protonation states followed by bond orders assignment and set up rotatable bonds of the receptors.[000243] Active site pockets of a protein molecule are the sites where the potential modulators bind to a protein. To perform these experiments, one may use one simulation boxthat determinates the searching area for the modulators. This theoretical procedure may be performed using the TRPV1 grid-box size with dimensions of x=20 A, y= 20 A, z=20 A and a center coordinates of X=106.82 A, Y= 82.40 A, Z = 90.48 A.[000244] Gibbs free energy of binding (FEB in Kcal / mol) for complexes structures of a receptor - modulator may be calculated using a scoring function which approximates the chemical potentials (AGbind). The docking free energy of binding (FEBdock) is defined by AGbindvalues for all docked poses of the formed complexes (protein- modulators) and include the internal steric energy of a given protein and modulators which can be expressed as the sum of individual molecular mechanics terms of standard-chemical potentials.[000245] A more negative value of FEB (kcal / mol) implies a higher affinity between the receptor and the different types of modulator substrates. The docking simulation results may be categorized as energetically unfavorable when the Gibbs free energy of the formed complexes is AGbind> 0 kcal / mol, pointing either to extremely low or complete absence of binding affinity, otherwise they are categorized having medium to high docking affinity.[000246] The docking simulation results may be categorized as energetically unfavorable when the Gibbs free energy of the formed complexes is ΔGbind≥ 0 kcal / mol, pointing either to extremely low or complete absence of binding affinity.[000247] In summary, the FEB threshold is 0 kcal / mol. FEB values higher than 0 means an absence of affinity for the receptor. If FEB is lower than 0 kcal / mol, there was affinity for receptors. Lowest FEB values means a better affinity for receptor.[000248] The A affinity represents the difference in binding affinity between a test compound and a reference compound. This value is calculated relative to each reference compound (benzoic acid and lactic acid). For each receptor, the A affinity is computed as the absolute value of the difference between the docking affinity of a target compound and the docking affinity of the reference compound, according to the following expression:By way of example:• Butyric acid (test compound): affinity = -4.477 kcal / mol• Benzoic acid (reference): affinity = -6.169 kcal / molΔaffinity =| −6.169 − (−4.477) |= 1.692 kcal / mol[000249] This A affinity calculation was performed for both reference compounds, across all test compounds. The results of the affinity analysis are provided in Table 3 below.[000250] In Table 3, the affinity value of each acid for its receptor (kcal / mol) is described by whether it was more negative (i.e., a higher affinity) or less negative (i.e., a lower affinity) than the affinity value calculated for benzoic acid as a reference.[000251] In Table 3, the compounds have been ranked in order of their A affinity, wherein 1 represents the smallest A affinity and 12 represents the largest A affinity, versus benzoic acid as a reference.Table 3[000252] It can be seen how all acids tested were comparable in terms of A affinity to either benzoic acid or lactic acid.Example 4[000253] Following the results of the binding affinity study, the test acid compounds were analysed for their transfer efficiency from e-liquid to aerosol.[000254] Acids were measured in e-liquid and aerosol sample types using Gas Chromatography coupled with Mass Spectrometry (GC-MS) and were compared based on how much was proportionally detected in terms of w / w (mass balance). E-liquid measurements were a direct calculation. For aerosol measurements, using a smoking machine, the amount of e-liquid vaped was determined based on the mass of the remaining e-liquid. Accordingly, the acids were measured in the residual e-liquid, initial e-liquid and in the emission captured in a filter pad used in a smoking machine.[000255] To measure the acids in the e-liquid, 10 mg of e-liquid was weighed into a vial and 990 mL of isopropanol added. 10 pL of Naphthalene_d8 at 10000 ppm was then added and the solution vortexed for 15 seconds, checking for complete homogenisation. The solution was then injected into the GC-MS.[000256] To measure the acids in an aerosol sample, the e-liquid was vaped using a smoking machine (LM4) aligned with the angle to 15° and connect to an e-liquid device set to the holder, which contains a filter pad (e.g. a Cambridge filter (ml)). The smoking machine was programmed with the following specifications: 70 puffs, 3 seconds puff duration, 55 mL puff volume, 30 sec puff interval.[000257] The analyzed extract is generated from the smoking of 70 puffs and 15°. The smoking analysis is carried out in a linear smoking machine with one impinger containing 10 mL of extractive solution and 45 mm filter pad. Each sample was analyzed in at least 3 replicates. The filter pads used in the smoking process were conditioned for 48 hours at 25°C and a maximum relative humidity of 60%.[000258] After smoking using the smoking machine, the filter pad was transferred to a 125 mL Erlenmeyer flask and 10 mL of extractive solution added. The samples were shaken in an orbital shaker at 250rpm for 30 minute. The samples were filtered with an aliquot of each sample into a 2mL vial, which was then injected into the GC-MS.[000259] The concentration of each acid in the aerosol can thus be calculated as follows:Concentration (mg / mL)=((Aa / Ai-l)x C) / DAa = analyte area;Ai = Internal standard area;I = Standard curve intercept;C = Internal Standard concentrationD = Slope[000260] Accordingly, the transfer efficiency can be calculated based on how much was proportionally detected in terms of w / w in the e-liquid versus the aerosol. The results of this study are set out in Table 4 below.Table 4[000261] It can be seen how the transfer efficiency of each of the acids is close to 100%. Hence, a further study was performed to determine and compare the sensorial contributions of the acids in the FMC-like space.[000262] Sensory attribute models are obtained from data collected through structured sensory evaluations, in which a trained panel quantifies the intensity of specific attributes (such as mouthful of smoke, impact, irritation, mouth drying, mouth coating, taste intensity, tobacco aroma, brightness, darkness and draw resistance) using standardized scales.[000263] The trained panel refers to a sensory panel composed of assessors who are specifically selected and trained to evaluate products in a structured and consistent way. They are familiar with a defined sensory vocabulary and with assessing the intensity of specific attributes (such as aroma, taste, mouthfeel and related sensations) using standardized scales and reference standards.[000264] In parallel, while the sample is being assessed by the panel, it is also analyzed through a High-Throughput Screening (HTS) platform (or GC-MS Gas Chromatography-Mass Spectrometry), enabling the acquisition of its chemical fingerprint in an objective and reproducible manner. The chemical fingerprint is analyzed through machine learning models that can predict sensory aspects of FMC based on chemistry (as described in Soares et al.2020. Journal of Chemometrics).[000265] The integration of these sensory and chemical datasets allows the development of statistical or multivariate models that link perceptual attributes to specific chemical profiles.[000266] The correlation coefficient is a statistical metric that quantifies both the strength and the direction of the relationship between two variables, typically ranging from -1 to +1: positive values indicate that an increase in a given variable is associated with an increase in the sensory attribute (increase), whereas negative values indicate that an increase in the variable is associated with a decrease in the sensory attribute (decrease), enabling an objective interpretation of how chemical composition influences sensory perception.[000267] Table 5 provides the direction for each tested compound in each attribute.Table 5[000268] As can be seen from the above data, whilst all acids had a comparable binding affinity and close to 100% transfer efficiency from the e-liquid to the aerosol, only isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, valeric acid, levulinic acid, 2-methylbutyric acid, isobutyric acid and acetic acid were identified as markers of FMC-like sensorial attributes. Specifically, each of these acids were found to contribute to drivers of FMC-like sensation. For example, each acid demonstrates an increase in respect of irritation, indicating that the presence of each acid promotes irritation. Additional benefits of these acids are outlined below.[000269] Isovaleric acid, 3-methylpentanoic acid, phenylacetic acid, 2-methyl butyric acid, isobutyric acid and acetic acid each are capable of darkening the flavour profile. Valeric acid and levulinic acid each are capable of brightening the flavour profile.[000270] As noted hereinabove, it may be desirable to ‘shift’ the profile of an aroma from a non-combustible substance delivery system to replicate and / or emphasise characteristics to mimic those of specific FMC products. For instance, as exhibited by certain tobacco varieties or blends thereof, such as Virginia, Burley, Oriental and the like. For example, Virginia may in some examples be characterised as brighter than other tobacco varieties, which may be associated with characteristics such as hay-like notes, lightness / mildness of flavour and or strength, and / or smoothness. Other varieties such as Oriental may be considered to have more complexity, depth and / or aromaticity. In some examples of FMC products, lighter and darker tobaccos may be combined in varying proportions to combine the foregoing characteristics to reflect consumer preference.[000271] By the terms “bright” and “dark”, is therefore meant modifying the aroma to “brighten” or “darken” towards that of a ‘bright’ tobacco and / or a ‘dark’ tobacco.Example 5Overview[000272] A study was performed to analyse tobacco extracts as disclosed herein to identify the compounds present using chromatogram deconvolution and El library matching. A list of compounds of interest was searched for in the untargeted results and the concentration of said compounds was calculated over three replicates. The concentration of compounds of interest were calculated over a period of 9 months, with values generated at T = 0, 1, 3, 6 and / or 9 months. Tobacco extract was stored at:• 25(±2)°C at 60(±5) % relative humidity (“Ambient” or “AMB”), or• 5(±3)°C (“Cold”).Materials and Methods[000273] 300 pL of a tobacco extract sample was weighed into a 50 mL centrifuge tube.10 mL of ethyl acetate was added to each sample which was then spiked with 100 pL of an internal standard (ISTD) solution. Samples were shaken at 300 rpm for approximately 2 hours on a platform shaker.[000274] Aliquots of each sample were transferred into 2 mL GC autosampler vials for analysis. Samples were analyzed via GCMS operating in Scan mode using a Restek Rxi 5ms column (30m x 0.25mm x 0.25pm).[000275] Agilent unknowns analysis software was used to process all samples using chromatogram deconvolution to find compounds whose spectra were then compared against an in house PCDL and NIST 20 for identification.[000276] Semiquantitative concentration results were obtained from the relative response of ID / d compounds compared to the ISTD 1-4,dibromobenxense (approximate concentration of 500 ng / mL).Results[000277] Results are provided below in respect of Extracts 2 and 4 that were analysed in Example 1.Stability of Alkaloids[000278] A number of alkaloids was determined to be present in Extracts 2 and 4. These alkaloids are indicated in the table below, and an exemplary concentration range for each flavour compound is indicated.Table 6[000279] GCMS Scan Flavour Analysis of the Extracts 2 and 4 was carried out over a period of 3 months with concentrations of each alkaloid compound of interest calculated at T = 0, 2 weeks, 1 month and 3 months under ambient or cold conditions.[000280] A concentration was also calculated after a 2 week and 1 month accelerated period in which the extract was stored at 40(±2)°C at 75(±5) % relative humidity (“accel”).[000281] The change in wt% versus T=0 is provided in Table 7 and 8 below - the wt% at T=0 is set to 100%.Table 7: Stability of Alkaloids in Extract 2Table 8: Stability of Alkaloids in Extract 4[000282] As indicated by Table 7 and 8 above, each of the alkaloids present in the extracts remain stable over a period of 3 months, including in accelerated studies at 2 weeks and 1 month. Each alkaloid remains stable and within the exemplary concentration range.[000283] The various examples described herein are presented only to assist in understanding and teaching the claimed features. These are provided as a representative sample only, and are not exhaustive and / or exclusive. It is to be understood that advantages, examples, functions, features, structures, and / or other aspects described herein are not to be considered limitations on the scope of the invention as defined by the claims or limitations on equivalents to the claims, and that other examples may be utilised and modifications may be made without departing from the scope of the claimed invention. Various examples of the invention may suitably comprise, consist of, or consist essentially of, appropriate combinations of the disclosed elements, components, features, parts, steps, means, etc., other than those specifically described herein. In addition, this disclosure may include other inventions not presently claimed, but which may be claimed in future.
Claims
CLAIMS1. A composition for a substance delivery system to provide a tobacco aroma,the composition comprising at least two diterpenoids derivable from a Nicotiana species, optionally wherein the total amount of diterpenoids in the composition is at least about 45 μg / g.
2. The composition according to claim 1, wherein the composition comprises at least three diterpenoids derivable from a Nicotiana species, at least four diterpenoids derivable from a Nicotiana species, or at least five diterpenoids derivable from a Nicotiana species.
3. The composition according to claim 1 or 2, wherein at least one diterpenoid is selected from the group consisting of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, farnesyl acetone, a cembrane diterpenoid, and a labdane diterpenoid.
4. The composition according to claim 3, wherein the cembrane diterpenoid is selected from the group consisting of cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, sclareol acetate, incensole, and incensole acetate, and / or wherein the labdane diterpenoid is selected from the group consisting of abienol, abienol acetate, labdenediol, and labdenediol acetate.
5. The composition according to any preceding claim, wherein the total amount of diterpenoids in the composition is at least about 100 μg / g, at least about 200 μg / g, or at least about 500 μg / g.
6. The composition according to any preceding claim, wherein at least one diterpenoid is cembrene or 2,7,11-cembratriene-4,6-diol.
7. The composition according to claim 6, wherein cembrene or 2,7,11-cembratriene-4,6- diol is the major diterpenoid present in the composition.
8. The composition according to claim 6 or 7, wherein the weight ratio of cembrene or 2,7,11-cembratriene-4,6-diol to the total amount of neophytadiene, phytane, phytol, isophytol, geranyl linalool, kaurenal, cembrene, sclareol, 2,7,11-cembratriene-4,6-diol, incensole acetate, abienol, and labdenediol in the composition is from about 0.4:1 to about 3.5:1.
9. The composition according to any one of claims 6 to 8, wherein cembrene or 2,7,11- cembratriene-4,6-diol is present in an amount of at least about 20 μg / g.
10. The composition according to any preceding claim, wherein the composition further comprises nicotine.
11. A composition for a substance delivery system, the composition comprising nicotyrine and at least one component selected from the group consisting of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, or anatabine.
12. The composition according to claim 11, wherein the at least one component is present in a total amount of at least about 250 μg / g.
13. The composition according to claim 11 or 12, wherein the weight ratio of nicotyrine to the total amount of myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine- T-N-oxide, caffeine, trigonelline, nornicotine, anabasine, and anatabine present in the composition is from about 1:10 to about 1:50.
14. The composition according to any one of claims 11 to 13, wherein the composition further comprises nicotine.
15. The composition according to claim 14, wherein the weight ratio of nicotine to the total amount of nicotyrine, myosmine, cotinine, n'-propylnornicotine, nicotine N-oxide, nicotine-1'-N-oxide, caffeine, trigonelline, nornicotine, anabasine, and anatabine present in the composition is from about 5:1 to about 50:1.
16. The composition according to any preceding claim, wherein the composition further comprises one or more components selected from: C6 to C18 substituted pyrazines, C6 to C18 substituted pyridines, sesquiterpenes, terpene alcohols, C3 to C24 carboxylic acids, C7 to C18 aromatic alcohols, C3 to C24 aliphatic esters, C7 to C18 aromatic esters, C4 to C18 lactones, phenol, C7 to C18 substituted phenols, norisoprenoids, bipyridine compounds, carboxylate esters, ethers, ketones or combinations thereof.
17. The composition according to any preceding claim, wherein at least one of the diterpenoids, nicotyrine, or components present is obtained by extraction from a tobacco source.
18. The composition according to any preceding claim, wherein the composition further comprises at least one tobacco extract.
19. A method for forming the composition according to any of claims 1 to 18, the method comprising contacting a tobacco material with a solvent, and extracting one or more of the compounds from the tobacco into the solvent.
20. A consumable comprising the composition according to any of claims 1 to 18, and a substrate material, optionally wherein the substrate material comprises a carrier material, a porous material, or a combination thereof.
21. A container or package containing the composition according to any of claims 1 to 18, preferably wherein the container or package is a pouched oral product comprising a saliva permeable pouch, or a cartridge for an aerosol provision system.
22. A substance delivery system comprising the consumable according to claim 20, or the container or package of claim 21.
23. The substance delivery system according to claim 22, wherein the system is a combustible aerosol provision system, a non-combustible aerosol provision system, or an aerosol-free delivery system.
24. An aerosolised formulation obtainable by aerosolising the composition according to any of claims 1 to 18 or the consumable according to claim 20.
